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Preface 
In autumn 2010, I started as a PhD candidate in a project entitled “PREDICTING HEALTH 
CARE COSTS, The use of simulation models in the Norwegian Health Care System”. Before 
the Nordic Health Economic Conference the following year, we succeeded in building a 
model to predict the future health care expenditures for Norway based on age, gender and 
regional differences, a so-called ‘age-only model’ (also referred to as the ‘naïve approach’). 
Based on feedback from several participants at the conference and the new data I received 
later that year, I was able to further develop my model to also take into account mortality. 
Subsequently I became part of the so-called “end of life costs debate”. 
Going forward I had the privilege to join Geir Godager and Hans Olav Melberg in their 
project regarding end of life costs for the Ministry of Finance in Norway. The project later 
resulted in the publication of “Hospital expenses towards the end of life”, which become part 
of my thesis. Later the same year, I started to work with Terje Hagen on his project assessing 
ambulance transports in Norway. Together with David McArthur, we wrote the paper 
“Modeling and predicting the cost of providing ambulance services in Norway”.  
I got the idea for the “steepening paper” during a lecture I gave in the course HMM4202 in 
2012 at the University of Oslo. Some of the students had some problems understanding the 
concept of the “red herring”; eager to try to make the concept more understandable, I wrote 
what later became a major part of the introduction to the steepening paper. Connecting this to 
a discussion I had with some colleagues earlier, I formed the foundation of this paper.
During my period as a PhD candidate, I also had the privilege to write two other papers; one 
with Kim-Rand Henriksen on Statistics Norway’s population projections and one on health 
care expenditures projections with Hans Olav Melberg. Both of the papers have been 
submitted, and hopefully will be found in Google Scholar soon. They are both highly relevant 
to the topics discussed in this thesis. 
Finally, please also note that paper 3 refers to a previous version of paper 2 called “Hospital 
expenditures and the red herring hypothesis: Evidence from a complete national registry”. 
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Summary 
 
In order to predict future health care expenditures and to understand the current financial 
situation, key variables that drive the expenditures have to be estimated. The aim of this thesis 
is to identify and estimate the impact of variables driving the health care expenditures within 
secondary care—in particular, the impact of age and mortality. Both the hospital expenditures 
and the emergency services are examined.
In order to quantify the impact of mortality and age on the expenditures, data covering all 
inpatient hospital admissions in Norway from 1998 to 2010 and all ambulance transports for 
the South-Eastern Regional Health Authority (Helse Sør-Øst) for 2009 and 2010 were 
applied. For hospitals, both age and mortality are suggested to drive current hospital 
expenditures. For ambulances, distance to hospitals and age are central in explaining the 
variation in costs. For hospitals and ambulances, health care expenditures are found to be 
higher for newborns and the elderly as compared to the rest of the population. 
We estimate that approximately 10% of total hospital expenditures are allocated to decedents 
within a calendar year. With data from 2010, the share is estimated to be 10.6% (for inpatient 
and outpatient care), while with data from 1998–2009, the estimated share is 9.0% (for 
inpatient care). Furthermore, our analysis suggests that mortality-related hospital expenditures 
are a decreasing function of age.  
The connection between the concepts of steepening and the red herring hypothesis are also
discussed. The red herring hypothesis states that it is time to death and not age per se that
drives health care expenditures, while steepening states that health care expenditures grow 
faster for the elderly population than the rest of the population over time. The two concepts 
are found to be independent. The empirical analyses also suggest that steepening is present for 
the Norwegian hospital sector for the time period 1998–2009 if newborns are excluded.
Furthermore, I put forth the hypothesis that steepening will be present for countries with high 
per capita health care expenditures in periods of increased per capita expenditures.
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Norwegian Summary (Sammendrag på norsk) 
 
For å forstå hvilken innvirkning eldrebølgen vil på det fremtidige helsevesenet, er det viktige 
å forstå i hvor stor grad aldring påvirker dagens helsekostnader. Formålet med denne 
doktorgraden er å estimere effekten av aldring og mortalitet (dødelighet) på helseforbruk. 
I doktorgraden anvendes data for ambulanseoppdrag i Helse Sør-Øst i 2009 og 2010 og 
somatiske sykehus innleggelser i perioden 1998-2010 i Norge. Analyser basert på data for 
dag- og døgnpasienter ved somatiske sykehus i perioden 1998-2009 viser at 9,0% av 
behandlingskostnadene ved norske sykehus gikk til personer i sitt siste leveår. Deskriptiv 
statistikk viser videre at 10,2% av alle behandlingskostnadene ved somatiske sykehus gikk til 
personer i sitt siste leveår i 2010 for dag- og døgninnleggelser og polikliniske konsultasjoner.
Det er også slik at for alle aldersgrupper viser analyser og deskriptiv statistikk at per capita 
forbruket av helsetjenester for personer i sitt siste leveår er høyere enn for den øvrige 
befolkningen. Videre viser analyser og deskriptiv statistikk at kostnader knyttet til død er 
fallende med alder.  
For ambulansetjenesten finner jeg at reisetid til sykehus og alderssammensetningen til
befolkningen har stor betydning for kostnadene knyttet til drift av tjenesten. Både nyfødte og 
eldre bruker tjenesten mer enn den øvrige befolkningen. Videre er det slik at lang reise vei til 
sykehus øker kostnadene for drift av ambulansetjenesten. 
Jeg finner også at begrepene red herring hypotesen og steepening er uavhengige. Det er med 
andre ord ikke slik at red herring hypotesen forkaster steepening eller motsatt. Red herring 
hypotesen sier at det høye helseforbruket knyttet til høy alder ikke blir drevet av alder i seg 
selv, men tid til død. Steepening er at helseforbruket per capita for eldre vokser fortere enn for 
den øvrige befolkningen. Videre viser analyser av data fra sykehussektoren i perioden 1998 til 
2009 at man ikke kan forkaste steepening i den aktuelle perioden, hvis man ekskluderer 
nullåringer. Jeg lanserer også hypotesen at steepening kan bli drevet av svingninger i 
helseforbruk. I perioder med stigende helseforbruk per innbygger vil det i følge hypotesen 
være steepening, mens det i perioder med avtakende helseforbruk ikke vil være steepening for 
land med i utgangspunktet høyt helseforbruk per innbygger slik som eksempelvis Norge og 
andre europeiske land. 
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1. Introduction 
There are several definitions of health. The World Health Organization (WHO) defines health 
as:
“… a state of complete physical, mental and social well-being and not merely the absence of 
disease or infirmity.”1
Health is again determined by several factors, including (but not limited to); medical 
treatment, lifestyle, environment, and genetics. Health care expenditures are investments that 
are intended to improve health. The influence of age and mortality on a society’s use of 
resources to improve health is widely discussed in the literature (see, among others,
Cadigan and Bugarin (1989), Kelley et al. (2013), Newhouse (1992), de Meijer et al. (2013)
and Rechel et al. (2013)). Age is often considered to impact health in two ways. First, the 
elderly, in general, have poorer health and therefore are expected to use more health care 
services. Second, decedents have higher per capita expenditures than individuals with the 
same age and gender (papers 1–2). As the probability of dying is strongly correlated to age, a 
higher fraction of the elderly will increase the number of decedents.
In The Organization for Economic Co-operation and Development (OECD), the increasing 
number of elderly is causing concern due to increasing health care expenditures. In Norway,
the fraction of the total population that is 67 years or older is expected to increase from about 
13% in 2012 to 17% in 2030 and 20% in 2040, according to Statistics Norway (population 
forecast September 2012).  
This concern about the increasing number of elderly people has been lessened after the 
introduction of the so-called red herring hypothesis. Fuchs (1984) and later Zweifel et al. 
(1999) suggest that age has little influence on health and thereby on health care expenditures;
rather, health care expenditures are driven primarily by the time to death. Several researchers
take part in the debate that follow (O'Neill et al., 2000; Zweifel et al., 2004; Breyer et al., 
                                                          
1 Preamble to the Constitution of the World Health Organization as adopted by the International Health Conference, New York, and 19–22 
June, 1946; signed on 22 July 1946 by the representatives of 61 States (Official Records of the World Health Organization, no. 2, p. 100) and 
entered into force on 7 April 1948.  
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2010; Colombier and Weber, 2011). If the hypothesis holds, an increase in life expectancy 
will have little influence on individuals’ lifetime health care expenditures, and less than 
previously expected (Stearns and Norton, 2004).
There is also a literature highlighting the growth rate for different age groups over time. A key 
term in this literature is steepening (Buchner and Wasem, 2006; Felder and Werblow, 2008).
This refers to the observation that per capita health care expenditures have grown faster for 
the elderly than for the rest of the population. Steepening has been observed in several OECD 
countries for the past years (de Meijer et al., 2013; Buchner and Wasem, 2006). If the trend 
continues, the health care expenditures will increase substantially due to both an increased 
number of elderly people and increased per capita health care expenditures for the elderly.  
In contrast, there are several studies (Seshamani and Gray, 2002; Christiansen et al., 2012;
Gerdtham et al., 1992) that cast doubt on the impact of demographic factors in general to 
explain trends in health care expenditures. Other factors, such as the general health condition 
of the population, technological progress and general economic growth, may overrule the 
effect of demographic variables. These factors may also vary for different parts of the health 
care sector. For example, geographical location of both the patients, hospitals and ambulances 
are crucial in determining expenditures for ambulance services (Norum and Elsbak, 2010).
The main aim of this thesis is to investigate which factors drive health care expenditures and 
in particular the effect of demographic factors (age and mortality) on the expenditures. Health 
care expenditures may include medical treatment (e.g., hospitalization), but may also include 
a wider spectrum of determinants of health (e.g., a healthier diet or increased physical
activity). This thesis will focus on medical treatment and in particular on the use of hospitals 
and ambulance services.
The outline for the thesis is as follows: Section 2 discusses the impact of both demographic 
factors and non-demographic factors in more detail, as well as a general debate surrounding 
the reasons for demanding health. Section 3 presents the overall aim of this thesis and specific 
aims from each paper. Section 4 gives a brief introduction to the Norwegian health care 
system. Section 5 presents the data applied in the empirical analysis included in the thesis. 
Section 6 presents the empirical methods applied. Section 7 presents the empirical results. 
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Section 8 is divided into three parts: limitations, future research and conclusion. The four 
papers follow at the end of this thesis.
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2. Background section: Drivers of health care 
expenditures 
The aim of this section is to introduce the general health economic theoretical and empirical 
literature in order to discuss the determinants of health care expenditures. While the main 
focus of this thesis is on the impact of demographic variables, I acknowledge there are other 
variables that influence health care expenditures.  
To understand the mechanism that drives investments in health (health care expenditures) the 
Grossman model, presented in Grossman (1972), stands as a key theoretical model. This 
section (section 2) will continue with a brief introduction to the model, followed by the 
implications of the model in connection to empirical findings and other theoretical papers.  
In the model, an individual values health due to three factors: 1) health in itself contributes 
positively to the individual’s utility, 2) more time in good health will increase time spent on 
labor (income-generating activities) and leisure, and 3) better health will increase length of 
life. There are two different versions of the model, the investment and the consumption 
model. The latter model considers length of life as exogenous, and hence ignores the third 
factor above. In the investment model, the first factor is ignored. The rest of this thesis will, to 
a large degree, ignore the differentiation between the models and mainly focus on the 
implications of the model framework.  
In the Grossman model, health is regarded as a capital good that may increase by investments. 
The investment may be medical services such as medication or hospitalization, or other 
investments such as a healthier lifestyle, diet, etc. The capital depreciates ( ) with age. In the 
model each individual is born with a health stock (H0), initial endowment, which they may 
add on to by investments (I), time and money. 
2.1 00010 )1( IHH   G
2.2 tttt IHH   )1(1 G
The model furthermore assumes no insurance market for health care services. The individual 
maximized his/her utility for health and other goods given the individual budget constraints 
for time and money. The individual may spend his/her time working, engaging in health-
G
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promoting activity, lost time due to illness (sick days) and leisure. The money may arise from 
income related to time working or other revenue (A0). In the rest of section 2, the money 
disposable for individual will be named wealth. 
Within this framework, Grossman (1972) discusses how the optimal level of investments in 
health (I*) and optimal health stock (H*) vary due to changes in the other factors included in 
the model. The rest of this section (2) will focus primarily on the effect of changes in ageing 
(depreciation rate; )G (section 2.1) and disposable income (wealth) (section 2.2), while it will 
briefly mention the additional factors (section 2.3). 
The reason to focus on wealth apart from ageing, the main topic in this thesis, is three-fold. 
First, a discussion on the causal effect of wealth upon health is applicable to the 
methodological debate raised in the Method section in connection with the “endogenity 
problem”. In the Method section it is debated whether mortality in equations 6.3–6.5 may be 
endogenous. A discussion on the causal effect of wealth upon health will contribute to this 
debate. Second, research has suggested that wealth may dominate the effect of ageing on 
future health care expenditures (Christiansen et al., 2012). Third, income is an observable 
factor that is easy to measure and available both at the national, regional and individual levels 
in Norway; therefore, it is feasible to incorporate into future research.  
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2.1 Ageing 
The effect of ageing in Grossman’s model is seen as an increase in the depreciation rate; 
hence, the cost of maintaining good health increases as an individual becomes older. This will 
again reduce the optimal level of health capital demanded by the individual. The investments 
in health may, however, increase due to inelastic demand.  Furthermore, Grossman (1972)
states on page 240 that: “Biological factors associated with aging raise the price of health 
capital and cause the individuals substitute away from future health until death is chosen.” 
From the empirical literature, there are several papers (including papers 1–4 in this thesis) that 
suggest that the per capita health care expenditures for the elderly are higher than for the rest 
of the population, when excluding newborns. There are researchers (Fuchs, 1984; Stearns and 
Norton, 2004; Zweifel et al., 1999) who suggest that an individual’s closeness to death (time 
to death) and not age per se, is what drives the association between observed health care 
expenditures and ageing (i.e. the red herring hypothesis).
More than 30 papers have been published on the red herring debate. The term red herring
was introduced by Zweifel et al. (1999). In this paper they studied the health care 
expenditures for 5000 individuals aged 65 years and older in Switzerland. They concluded 
that time to death was more important than age in predicting future health care expenditures. 
This study has, however, been criticized for methodological weaknesses (Salas and Raftery, 
2001; Seshamani and Gray, 2002; Felder et al., 2010; Häkkinen et al., 2008). In the years that 
followed, several papers have been published to further debate this hypothesis; some do not 
reject the hypothesis (Zweifel et al., 2004) while others do reject it (Colombier and Weber, 
2011). A more in-depth description of a sample of papers in the red herring debate in 
connection to methodological issues will be presented in section 6.2. 
In the continuation of the red herring debate some researchers (Melberg and Sørensen, 2013;
Madsen, 2004; Breyer and Felder, 2006) have presented the hypothesis that the high health 
care expenditures are associated with aging will move to higher age groups as length of life 
increases. Furthermore, that mortality related expenditures that are suggested to be decreasing 
by age are expected to move to higher age groups as length of life increases. This is referred 
to as shift. Melberg and Sørensen (2013) test the hypothesis comparing Norway and Denmark. 
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The countries are similar in many aspects, but have different life expectancy (Melberg and 
Sørensen, 2013). By comparing the two countries, Melberg and Sørensen (2013), do not reject
the shift hypothesis. 
While the red herring examines the connection between age, time to death and health care 
expenditures, there are also papers that discuss the relationship between age, time and health 
care expenditures—the steepening debate. There are few studies that have steepening as their 
primary topic (paper 3; Felder and Werblow, 2008; Buchner and Wasem, 2006). There are, 
however, many studies discussing the phenomenon, some of the studies (see, among others, 
Breyer et al. (2010), Dormont et al. (2006) and de Meijer et al. (2013)) apply the term, 
steepening, and others do not apply the specific term (see, among others, Seshamani and Gray 
(2002) Meara et al. (2004), Barer et al. (1987), Mendelson and Schwartz (1993) and Cutler 
and Meara (1998)). All the studies support, apart from Seshamani and Gray (2002) and Felder 
and Werblow (2008), that there is a bias towards more health care expenditures for elderly 
people per capita compared to the rest of the population. Seshamani and Gray (2002) study
Japan, Canada, Australia, and England and Wales, and for the case of England and Wales for 
the time period 1993-1997, they do observe a decline in growth in per capita expenditures for 
the elderly people compared to the rest of the population, for the other countries the opposite
holds. Felder and Werblow (2008) is based on data from Switzerland, and do reject 
steepening. The above mentioned studies may, however, be hard to compare due to different 
age groups included in the studies and methodological differences. In the method section a 
further description of the methodological issues are presented. 
With regard to the underling mechanisms that may induce steepening, de Meijer et al. (2013)
suggest that the ageing population induces the medical technology to be targeted towards the 
elderly. This may again lead to health care expenditure growth for elderly. Felder and 
Werblow (2008) propose that, apart from technology, a potential driver of steepening may be 
biological factors, e.g. changed morbidity patterns. Furthermore, paper 3 summarizes several 
of the papers on the underling mechanisms of steepening, and concludes that the research is 
vague and points at both biological and technological factors. This may be a target for future 
research. 
Changes in morbidity and mortality patterns are further debated in Fries (1983), Fries and 
Crapo (1981) and Barer et al. (1987). Fries and Crapo (1981) suggest that mortality 
 
 
18 
 
compresses over time, i.e., rectangularization of survival curves. Furhtermore, Fries (1983)
suggested the hypothesis that morbidity compresses over time. In this study it is suggested 
that as medical technology becomes better and individuals become healthier, the period of 
serious illness will be compressed towards a short period of time at the end of life. Barer et al. 
(1987) discuss how the compression of mortality and morbidity influence on health care 
expenditures. They argue that, depending on the preferences of the society, the expenditures 
may either increase or decrease. In a situation where the society accepts “natural death”, the 
expenditures will decrease. Conversely, if the society uses all resources available to reduce 
morbidity, expenditures may increase. 
Another branch of the literature on ageing and health care expenditures discusses the share of 
total health care expenditures used by decedents. Table 2.1 presents some of these studies that 
measure care in the last year of life. The studies each include different groups of the 
population and different sectors of health care; subsequently, direct comparisons may be 
difficult. For example, Häkkinen et al. (2008), Emanuel (1996) and Hogan et al. (2001) use 
data containing only the elderly, while the other studies contain data encompassing a wider 
age range. The only study with Norwegian data within the past 25 years—apart from papers 1 
and 2—is Nord et al. (1989), and is based on several restrictive assumptions due to data 
limitations.
Table 2.1: Share of total health care expenditures used by indivduals in the last year of 
life 
Paper Country Share used on decedents
Polder et al. (2006) Netherlands 11%
Häkkinen et al. (2008) Finland 14%
Hogan et al. (2001) United States 33%
Emanuel (1996) United States 27%
Nord et al. (1989) Norway 18–26%
There are, however, researchers who question the effect of age and mortality when 
investigating trends in health care expenditures. Some claim that the effect of ageing is ruled 
out, when including other factors such as income and technological changes, when 
investigating trends in health care expenditures. Christiansen et al. (2012) summarizes the 
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literature on health care expenditures and ageing, and suggests that ageing may only explain a 
modest increase in health care expenditures, while other factors contribute to the majority of 
the increase. Seshamani and Gray (2002) state on page 287:
“[Of the] Many cross national studies that have examined the determinants of health 
care expenditures in developed countries, only one found the age structure of the 
population (usually measured by the percentage of population above 65) to be a 
consistently significant explanatory variable alongside the effects of income, lifestyle 
characteristics, and environmental factors.” 
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2.2 Wealth  
In the Grossman model, higher A0 will increase the investment in both health care goods and 
in other goods. In the consumption model, the effect of increased hourly wage is uncertain 
and depends on the individuals’ preferences for health and other commodities. In the 
investment model higher hourly wage increases the value of time. This will again lead to 
increased investments in health in order to increase the amount of healthy days. In contrast, 
the alternative value of time increases, which may lead to reduced investments in health. 
Getzen (2000) summarizes the empirical literature on income elasticity on health care 
expenditures. At the national level increased income (gross domestic product (GDP)) is 
associated with higher health care expenditures according to the review. This is also 
supported in the report from the OECD (OECD, 2013). They report a positive correlation 
between GDP per capita and health care expenditures per capita. Also Baltagi and Moscone 
(2010) suggest an income elasticity above zero at national level for the majority of countries 
included in their study. At the individual level, income elasticity (the effect of increased 
personal wealth on health care expenditures) is by some studies suggested to be close to or 
even below zero (Getzen, 2000).
The rest of this section will briefly summarize the literature on the causal effects between 
wealth and health.  There are several studies investigating the causal effect from wealth to 
health and from health to wealth. Kverndokk (2006) investigates the connection between 
health and wealth. The study summarizes the literature and concludes that there is a strong 
correlation, but not necessary a strong causal relationship, from increased wealth to increased 
health. 
Wealth may, according to Kverndokk (2006), influence health in several ways. For example, 
greater wealth may give you more access to health care services. Even under a national health 
service system—such as the health care systems found in Norway and the United Kingdom—
where many health care services are free of charge for the patient, there are still services that 
require out-of-pocket payments. These services will, to some degree, be more accessible to
patients with higher incomes. Kverndokk (2006) also points out that more wealth gives you 
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the opportunity to consume healthier food. Furthermore, individuals with greater wealth may 
also have more resources to request more health care services. 
Furthermore, several empirical studies suggest that there is a causal relationship from wealth 
to health. Meer et al. (2003) find that inheritance has a small, but positive effect on health. A 
British study conducted by Attanasio and Emmerson (2003) on the elderly also finds a postive 
effect from wealth on health and probability of survival. Frijters et al. (2005), which analyses
the effect of the reunification of Germany on health with a transfer of wealth from West to 
East Germany, also find a positive but small effect. There are also studies that do not find a 
clear positive effect (Adams et al., 2003; Attanasio and Emmerson, 2003). Chapman and 
Hariharan (1996) suggest that the marginal effect of increased income on increased length of 
life is decreasing with increased income level. OECD (2013) also report a positive correlation 
between health care expenditures per capita and expected length of life at birth, but the effect 
is decreasing with increased health care expenditures per capita.
There may also be a causal relationship from health to wealth. In the Grossman model, 
improved health will result in more time available for other activities and it may also act as an 
incentive to invest in health as the probability of living longer increases. Michaud and Van 
Soest (2008) suggests that there is a causal relationship from health to wealth, but not from 
wealth to health. The study applies data for elderly in the United States and emphasize the 
conclusion may change if other age groups are included. Furthermore, both Black et al. (2007)
and Behrman and Rosenzweig (2004) find that low birth weight is related to low education 
and income. This may point in the direction that there may be a casual relationship from 
health to wealth. With regard to investment (I), good health gives more potential time to 
health-promoting activities and income-generating ativities. However, the mariginal utility of 
health decreases with the level of health. As such, the marginal gain from investments in 
health may decline, which alone points to reduced investments in health. 
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2.3 Other factors and concluding remarks 
 
Both within the framework of the Grossman model and in other economic literature, it is 
suggested that several other factors besides ageing and wealth may drive health care 
expenditures. Other factors may include, for example, changes in prices, and technological 
changes (Medeiros and Schwierz, 2013; Wong et al., 2012; Newhouse, 1992; Dybczak and 
Przywara, 2010).
In standard economic theory increased prices for normal goods will reduce the demand for the 
good. In the Grossman model, increased prices on health care services will make investments 
in health care services less attractive and will therefore reduce the investments in health. The 
Rand Health Insurance Experiment investigated how individuals were influenced by the 
prices of health care services. In the experiment a group of individuals in the United States
were randomly assigned to different insurance plans. Based on the experiment, Newhouse et 
al. (1981) concludes that the individuals with generous plans used more health care services 
than those who were assigned to plans with more cost sharing. Brook et al. (1984) conclude
that the insurance plan of the participants influenced, to a limited degree, the health status of 
the participants, even though they find a small positive effect of the generous plans.
So far section 2 has mainly focused on demand side effects. Health care expenditures may, 
however, also be influenced by several supply side effects (Jegers et al., 2002; Gerdtham et 
al., 1992). Robinson (2001) suggests that the payment mechanisms for physicians may 
influence the amount of services provided. According to the paper, fee-for-service gives 
incentives to “rewards bad inappropriate service”, while a capitation system rewards “den[ial 
of] chronically ill”. Papers 1–3 are based on data from hospitals in Norway that are 
compensated by a mix of fee-for-service (activity based financing) and capitation. 
In summary, health is determined by many factors, among which medical care is only one.
This thesis is limited to analysing how expenditures in medical care and in particular hospitals 
and ambulances are influenced by age and mortality.
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3. Aims 
 
The overall aim of this thesis is to identify and estimate the impact of variables driving 
health care expenditures for secondary care, by specifically considering the impact of 
age and mortality on both hospital and ambulance services expenditures.
• Paper 1: 
Quantify the share of the total hospital expenditures used on individuals in their last calendar
year of life in Norway. Furthermore, investigate differences between different age groups and 
health care expenditures. 
• Paper 2: 
The aim is twofold. Firstly, we aim to quantify the impact of age on mortality-related 
expenditures. Secondly, we aim to assess the influence of changing longevity on hospital 
expenditures that occur as death is postponed to higher ages where mortality related 
expenditures are lower.
• Paper 3: 
The aim of this paper is three-fold. First, measure changes in health care expenditures over 
time, in order to test if steepening may be rejected.  Second, present mechanisms that may 
induce steepening, as presented in the literature.  Third, explain the connection between red 
herring and steepening.
• Paper 4: 
Study how regional demography and accessibility patterns influence the cost of providing 
ambulance services. Furthermore, project the cost and demand for ambulance services based 
on population projections.
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4. Study setting 
 
The study setting, for example financial incentives for health care providers, may influence 
both the total amount of health care expenditures and potentially also the distribution on an 
individual level. The data applied in this thesis are from Norway. Norway has high per capita 
health care expenditures compared to other countries in the OECD. Only the United States has
higher per capita health care expenditures adjusted for purchasing power parity.2 Life 
expectancy at birth is also high in Norway with 81.4. In comparison the life expectancy in the 
United States is 78.7.2
Norway has a national health service (NHS). Similar health systems are found in Sweden, 
Denmark, New Zealand and the United Kingdom. The primary source of financing of the 
health care in a NHS system is through taxes and many health care services do not require any 
out of pocket payments. The use of health care services may therefore reflect, to a larger 
degree than in a health care system financed primarily by out-of-pocket payments, the health 
condition and not the income of the patient.  Karlsson and Klohn (2013) support this view in 
their paper on long term care and the red herring hypothesis in Sweden. The paper claims that 
the funding system allows the indivudal’s health care expenditures to reflect the need 
(morbidity and physical abilities) rather than income constraints at the individual level.  On 
the contrary, as the price for the health care services faced by the patient (consumer) do not 
reflect the actual cost, moral hazard problems may be present (Hsiao and Heller, 2007;
Colombier and Weber, 2011).
There are two sectors of the health care provision that are included in the empirical part of this 
thesis: somatic inpatient hospitals and ambulances. The ambulance service is run by the 
central government together with the hospitals (specialist care) while primary care and 
community-based models of emergency care (legevakt) and general practitioners (GPs) are 
organized by the municipalities (local level) (Johnsen and Bankauskaite, 2006). The 
specialist care is further divided into four health trusts. Patient transport stands for 5.8 % of 
the total spending of the health trusts, about 4.5 billion Norwegian Kroner. Patient transport 
takes place both by road (ambulances, taxies and buses), sea (boats) and air (helicopters and 
                                                          
2 According to The Organization for Economic Co-operation and Development (OECD) statistics 
(stats.oecd.org) for 2011.
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ambulance planes) (NOU, 2008). This section will further focus first on hospitals and then
on ambulances.
4.1 Hospitals  
Hospital stays are free of charge for patients in Norway in public hospitals. In private 
hospitals there may be out-of-pocket payments. However, less than 1% of all health care 
spending for both inpatient and outpatient services is associated with out-of-pocket payments
(Huseby et al., 2013). The general practitioners (GP, family doctors) work as gatekeepers for 
the hospitals, and apart from emergency care treatment all patients must have a referral from a 
GP.   
The hospitals in Norway are financed through a mix of per capita and activity-based financing 
(ABF), i.e., a mix of prospective fixed and prospective variable payment. Before 1997 the 
hospitals in Norway were financed only based on per capita funding (global budgets). The per 
capita funding were based on socioeconomic characteristics of the inhabitants in the 
catchment area of the hospital (Magnussen and Solstad, 1994). Since 1997 the share financed
through ABF has changed several times (The Norwegian Directorate of Health).3 The aim of 
the introduction of the activity-based component was to reduce both hospitals cost per 
treatment and waiting time.
Before the introduction of ABF for all public hospitals in Norway, it was tried at four pilot 
hospitals in 1991. The result was the pilot hospitals, to a small degree, changed the activity
level compared with the fixed grant system (Magnussen and Solstad, 1994). After the 
introduction Yin et al. (2013) finds that there is a negative correlation between length of stay 
and the share paid by ABF. In general there are, however, few studies investigating this 
relationship for the case of Norway.
In the period of observations for hospital in this thesis, 1998–2010, there have also been 
several other major reforms in the hospital sector. In 2001, the central government took over 
the management of the hospitals from the counties. In 1999, the Act for Patient Rights was 
                                                          
3 Share paid by activity based financing (ABF): 1997: 30%; 1998: 45%; 1999: 50%; 2000: 
50%; 2001: 50%; 2002: 55%; 2003: 60%; 2004: 40%; 2005: 60%; 2006–2010: 40%.
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introduced. The aim of the act was to ensure the inhabitants in Norway received equal and 
good quality health care services. This may again lead to increased health care expenditures. 
4.2 Ambulances  
The emergency medical service (EMS) in Norway has undergone several reforms in the past 
few years (Norum and Elsbak, 2010; Norum and Elsbak, 2011; Langhelle et al., 2004). In 
1996, a certificate of competence for ambulance workers (paramedics) was introduced, called 
“fagbrev”. The required training consists of two years of theoretical training in high school,
followed by two years of practical training. Prior to the certificate being established, the 
health trusts themselves organized the training of ambulance staff, and the training was often 
limited. In 2003, further education for ambulance workers was introduced at the University 
level.  
Since 2005, by law, it is required that at least one of the workers in the ambulance have the 
certificate. The law also requires that all ambulances should be operated by at least two 
workers. In some areas, mostly rural, the ambulances previously were manned by only one 
worker, the driver. The law also set educational standards for the staff in ambulance planes, 
boats and helicopters. These reforms have increased the expenditure of the EMS in Norway
(Norum and Elsbak, 2010; Norum and Elsbak, 2011). This thesis does not investigate the 
changes that occurred during the reforms in EMS, but investigate the current patterns of 
expenditures. This is important in order to predict the future expenditures for the EMS 
services.
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5. Data 
 
Access to registry data from the Norwegian Patient Registry (NPR) as well as to records of all
ambulance transports in the South-Eastern Norway Regional Health Authority (Helse Sør-
Øst), provided the basis for the analyses performed in this thesis. The record of ambulance 
transports is named Akutt medisinsk informasjonssytem (AMIS). Since 1997, NPR has 
recorded every hospital admission in Norway for somatic hospitals. Note that NPR only 
record diagnostic related groups (DRG) for outpatient care from 2008. In addition, papers 2–4
applied data from Statistics Norway on the number of inhabitants. In paper 1, data from the 
National Resident Registry (NRR) was applied. Furthermore, paper 4 applied Geodata for 
travel times between municipality centroids. Table 5.1 presents an overview of the data
applied by paper. 
Paper 1 linked 2010 NPR data with the NRR record that documented whether the patient died
or not (d=1 if the patients dies, d=0 otherwise), and did not contain any information on the
diagnosis of the patient. The data were on an individual level, i.e., it was possible to follow an 
individual between different hospital admissions. Apart from demographic information (e.g., 
age and gender) of the patients, the dataset also contained information on the cost of the 
treatment based on DRG for both inpatient and outpatient somatic hospital services.
 
Papers 2 and 3 applied NPR data for the time period of 1998–2009 for inpatient somatic 
hospital services where a total of 14.5 million admissions were observed. In this dataset it was 
not possible to track individuals between different hospitals admissions, which distinguishes 
this dataset from the dataset applied in paper 1. Papers 2 and 3 contain the following 
information from each hospital admission: the patients’ home municipality (place of 
residence), age, gender, the year of hospital admission, and cost of treatment based on the 
DRG. As the variable of interest is on the per capita level, the data was aggregated to the 
smallest possible cell, defined by age, gender, year and municipality. This resulted in a data 
set with 1 093 920 cells (106 age groups × 2 genders × 12 years of observation (1998–2009) ×
430 municipalities).
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Finally, paper 4 applied data for road ambulance transports in the largest regional health 
authority, Health Southeast, in Norway from 2009 to 2010. Health Southeast covers the south-
eastern part of Norway, with 2.7 million inhabitants, which is roughly 3/5 of the total 
population of Norway. There are 197 ambulances in Health Southeast and 498 in all of 
Norway. The health trust covers an area of 104 071 km2, approximately two times the size of 
Denmark. The area is sparsely populated with the exception of areas along the coastline. The 
hospitals that are the most advanced in treating patients with multi-trauma and other severe 
illnesses are located in Oslo (the capital of Norway). Areas included in Health Southeast 
could require a traveling distance to Oslo of up to 379km (by road).
 
The data applied in paper 4, contained information on the age of the patient as well as the 
place of residence and travel time in the ambulance. It was not possible to distinguish between 
individuals, only ambulance trips. The structure of the data is, therefore, similar to the applied 
in papers 2 and 3. For each ambulance station, information on the total expenditures each year
was available. By combining the travel time and total expenditures, the price per ambulance 
minute for each ambulance station was calculated. The data was further aggregated at the
municipality level and averaged over the two years of observations, resulting in 140
observations, one for each municipality included in the study.
Furthermore, paper 4 applied the population predictions from Statistics Norway for the 
projection of future health care expenditures. Statistics Norway presents several different 
population projections; for example, high, low, and the main alternative (in Norwegian: 
Hovedalternativet eller “MMMM”). In the paper the main alternative was applied.   
Section 6 (Methods) also presents regression analysis based on the same dataset as applied in 
papers 2 and 3. In section 8, the number of overnight stays by age and cost estimated by DRG 
for inpatient somatic hospitals for the time period 1998–2009 from NPR are presented.
 
 
29 
 
Table 5.1: Overview of data applied by paper
Name of paper Name of data set Variables applied
Paper 1: Hospital expenses 
towards the end of life
NPR (in- and outpatients in 
somatic hospitals) /
National Resident Registry
Year: 2010
Age, gender, individual death
record, time (year), estimated 
cost based on DRG, number of 
inhabitants
Paper 2: The association 
between age and mortality
related hospital expenditures
NPR (inpatients in somatic 
hospitals) / Statistics Norway
Year: 1998–2009
Age, gender, number of deaths,
time (year), estimated cost 
based on DRG, place of 
residence (municipality),
number of inhabitants
Paper 3: The impact of ageing 
on health care expenditures: A 
study of steepening
Paper 4: Modeling and 
predicting the cost of providing 
ambulance services in Norway
AMIS / Statistics Norway /
Geodata
Year: 2009–2010
Statistics Norway population 
prediction
Year: 2013–2040
Age, number of deaths, time 
(year), travel time in 
ambulances, total expenditures
by ambulance station, number 
of inhabitants, travel times 
between municipality centroids
Predicted future population, 
age, year
Thesis: Section 6
Section 8
The same data set as applied in 
papers 2 and 3
NPR / Statistic Norway
Year: 1998-2009
Same variables as in papers 2 
and 3
Age, year,  length of stay, 
estimated cost based on DRG,
number of inhabitants
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6. Method 
 
This section will, first, present “the simple model” that forms the foundation of the methods
applied in this thesis. Second, it expands the discussion raised in paper 3 with regard to the 
concepts steepening and the red herring hypothesis. Finally, a brief summary of the empirical
methods applied in each paper will be presented.
 
6.1 The simple model 
This thesis investigates how health care expenditures (Y) for an individual (i) is influenced by 
demographic factors; age (a), gender (q)4 and death (d), and other factors (x):
6.1 ),,,( xqdaYi
With regard to the marginal effect of the explanatory variables in equation 6.1, the effect of 
ageing is discussed in section 2. To summarize section 2, the effect of both age and 
mortalities is suggested to be positive in many empirical studies (see, among others, Hogan et 
al. (2001) and Zweifel et al. (1999)), but the effect is not certain within the framework of 
Grossman (1972).
The share of total health care expenditures used by decedents (d=1):
6.2 ¦ ¦ ¦
      ¹¸
·
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Section 2; do not discuss the effect of gender. Several studies (Mustard et al., 1998; Lubitz et 
al., 2003; Stearns and Norton, 2004) report gender differences with regard to health care 
expenditures. Though Mustard et al. (1998) suggests, that the genders have similar 
expenditures patterns when controlling for “differences in reproductive biology and higher
age-specific mortality rates” (page 1678).
With regard to the other factors driving health care expenditures (x), there are numerous
variables that may be included. In section 2 mention several factors that influence health care 
expenditures apart from gender, age and death, e.g. income and health care reforms. In the 
                                                          
4 0 if male, 1 if female
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analysis in paper 4, x is assumed to include jobs per capita, accessibility to hospital, and 
education. In papers 2-3 the effect of other variables (x) is assumed to be zero. The issue of 
potential omitted variables is further debated in section 8.1 (Limitations).
If the relationships between explanatory variables and health care expenditures are assumed to 
be linear, the health care expenditures may be presented as equation 6.3ZKHUHİLVWKHHUURU
term: 
6.3 iii xqdaY HDDDDD  43210
The per capita health care expenditures for a group (g) are denoted by .gY The mortality rate 
in group g is denoted by m.
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6.5 gggggg xqmaY NEEEEE  43210
g is in papers 2 and 3 defined by age, gender, municipality and year, while in paper 4 it is 
defined by municipality. In paper 4, ga indicates the share of individuals with a given age,
while in papers 2 and 3 it is a dummy variable indicating age group. Furthermore, in paper 4 
mg is the mortality rate in the municipality, while in papers 2 and 3 it is the mortality rate for a 
group characterized by age, gender, municipality and year.  
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6.2 Relation between concepts 
In the debate over health care expenditures and ageing, two concepts are often mentioned in 
the literature, the red herring hypothesis and steepening. The rest of section 6.2 will briefly 
introduce these concepts, keeping the same notation as defined above (“The simple model”). 
Red herring hypothesis
The red herring hypothesis was introduced by Zweifel et al. (1999). They specified the 
hypothesis that health care expenditures for individual (i) are dependent on time to death
(quarters to death (k)), but independent of age: 
6.6
 
0
,, zw
w
i
i
k
akqY
6.7 0),,(  w
w
a
akqYi
The connection between 6.5 and 6.6–7 is not straightforward. Felder and Werblow (2008)
state that estimating 02 !E

“add[s] on to the finding of the red herring literature”. Estimating
2E , however, only touches upon the first argument of the red herring hypothesis, i.e.,
equation 6.6. The second argument, that age may be ignored, is not tested. Furthermore, the 
hypothesis as formulated by Zweifel et al. (1999) uses quarters to death (k). In the simple 
model the variable (d) only indicates death within a calendar year, i.e., N,QFRQFOXVLRQ,
estimating 2E does not test the red herring hypothesis (paper 3). 
Not discussed in the paper by Zweifel et al. (1999), but in papers 1 and 2, is that mortality-
related health care expenditure may in and of itself be dependent on age ( 05 zE in equation 
6.8). If that is the case, ignoring age when predicting health care expenditures will lead to 
biased results. 
6.8 gggggggg amxqmaY NEEEEEE  543210
As discussed in section 2, one motive for demanding health is to increase the amount of an 
individual’s healthy days. The expected number of potential healthy days declines with age,
hence, the expected sign of 5E is negative. On the contrary, one may argue the expected 
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length of life when getting a serious illness is low regardless of age. This should in turn imply 
that the sign of 5E is insignificant, i.e. the mortality-related costs are independent of age.   
The section continues with a short presentation of some papers in the red herring debate in 
connection to 6.6 and 6.7. The aim of the presentation is to discuss how the studies define the 
red herring hypothesis and thereby give an overview of the applied definitions.  
Karlsson and Klohn (2013) use aggregated data on long term care from Sweden. In their
paper they use the probability of dying within the next two years as a proxy for time to death 
(k), and the share of individuals with a certain age as a proxy for age ,( ga where g is 
municipality). They conclude that the effect of time to death is positive, but that “age remains 
the main driver” of long term care expenditures. They state on page 6 that “our results give 
evidence for the existence of the red herring, but age itself seems to have a strong impact on 
LTC (long term care) after controlling for mortality.” 
Colombier and Weber (2011) use data from Switzerland and include several other factors
besides age and proximity to death in their regressions, among them income. They conclude 
that proximity to death is of marginal importance and argue that they have “further evidence 
against the red herring hypothesis”.
Stearns and Norton (2004) use data from Medicare in the United States. They treat the “red 
herring” as an omitted variable problem by assuming the coefficient of time to death to be 
zero and then including it in the model. They find the interaction between age and time to 
death to be positive and significant. Furthermore, several of the coefficients are suggested to 
be significant in both models. They do not explicitly make conclusions with respect to the red 
herring hypothesis, but they state “it is time for time to death”. The statement and paper in 
general have been interpreted in favor of the red herring hypothesis (Zweifel et al., 2004).
To summarize, some researchers refer to 6.6 (time to death) when referring to the “red 
herring”, while others refer to both 6.6 and 6.7. The primary hypothesis tested is, however, 
similar across studies; may time to death and/or age be ignored when estimating health care 
expenditures. In the rest of this thesis, I will refer to the red herring hypothesis as defined by 
Zweifel et al. (1999) (6.6 and 6.7).
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There are several methodological problems raised in the red herring debate (Salas and
Raftery, 2001; Seshamani and Gray, 2002; Felder et al., 2010). The two main problems 
addressed are (Häkkinen et al., 2008; paper 2): 1) that the point of death (time to death), i.e.,
also mortality, may be dependent on health care expenditures 0),(( zmcorr gN ), and 2) the 
probability of dying is strongly correlated to age, hence it might be a multicollinearity 
problem. In paper 2 both of these issues are discussed in detail.
With regard to the first methodological issued raised above, paper 2 argues that in Norway 
during the period of observation, it may be plausible that even though in an international 
context there is a causal relationship from health care expenditures to time to death, it may not 
be the case in the data applied. In the paper 2, we argue that due to decreasing marginal 
returns to scale, life expectancy may to a limited degree be influenced by health care 
expenditures for such high levels of health care expenditures as are observed in the data. In 
the background section of subsection 2.2 (wealth), refers to, Chapman and Hariharan (1996)
and OECD (2013) who indicate that there might be a decreasing returns to scale from 
investments in health care expenditures measured in life expectancy. 
Furthermore, paper 2 tests the hypothesis that mortality is independent of health care 
expenditures, based on the data set applied in the study with two stage least squares (2SLS).
The mortality rate for the year (t-1) is applied as an instrument for the mortality rate in year t. 
With regard to the second methodological issue mention above (i.e., multicollinearity), paper 
2 suggests that the problem is negligible as the data set is large, with more than one million 
observations. Paper 4, in contrast, has a small sample with only 140 observations, and the 
problem of multicollinerity may therefore be larger for the analysis in paper 4 than in papers
2–3. This issue will be further discussed in section 8.
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Steepening
The term steepening was introduced by Buchner and Wasem (2006) and states that health care 
expenditures for the elderly grow faster than for the rest of the population:
6.9 1],64,30[1],79,65[],64,30[],79,65[ //  ! tatatata YYYY ,
where taY ],79,65[ is the per capita expenditures for the elderly (aged above 64 and below 80) in 
year t.  
In paper 3, I generalized the definition to include all individuals and defined the younger 
group as those less than 65 (i.e., 0 to 64) and the elderly group as those older than 64 (i.e., 
65+).
6.10 1],64,0[1],106,65[],64,0[],106,65[ //  ! tatatata YYYY
Later, Felder and Werblow (2008) defined steepening as
6.115 0
),(ln2 !ww
w
ta
taYg
Their argument for introducing the new definition was that it was more flexible with respect 
to model specification. Note that Felder and Werblow (2008) also include mortality in the 
function of .gY However, as estimated in paper 3, the cross derivative of mortality over time
and age  tam www /2 is small, and therefore for the sake of simplicity the rest of this section 
ignores the effect of mortalities when defining steepening. Furthermore,  Buchner and 
Wasem (2006) defined steepening in three dimensions (age, time and per capita health care 
expenditures (6.10)), and ignoring mortalities will make the definitions (6.10 and 6.11) more 
comparable.
The argument for taking the natural logarithm was that they claimed that health care 
expenditures grow exponentially over time. Paper 3 argues that per capita health care 
expenditures are slightly better explained by a linear model than an exponential model in the 
data set applied in the study (NPR 1998–2009), hence:
                                                          
5 Note that Felder and Werblow (2008) and paper 3 also include gender and mortality in the regression when 
testing steepening.
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6.12 0
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w
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taYg
where
6.13 ggggg tatqaY NEEEEE  76310
Both paper 3 and Felder and Werblow (2008), however, do not discuss under what conditions 
definitions 6.10, 6.11 and 6.12 may give different results with regard to steepening. In general 
6.12 presents the percentage increase in per capita health care expenditures as both age and 
time increase with one unit, while 6.12 presents the increase in absolute value. However, for 
testing the presence of steepening the sign 7E is the matter of interest, and the magnitude is of 
secondary interest.
Furthermore, as mentioned in paper 3, 6.10 does not distinguish between differences within 
the young and old, while 6.11 and 6.12, as done in both paper 3 and Felder and Werblow 
(2008), allow for more variation within the two age groups.
To compare the results from 6.11 and 6.12, regressions on 6.13, both with and without 
applying the logarithmic transformation of the dependent variable, are performed, applying 
ordinary least squares (OLS) and the same data set as applied in paper 3 (NPR 1998–2009).
Note that infants less than one year of age are excluded from the regression. The reason to 
exclude the zero-year-olds is that paper 3 supports steepening when excluding this group.6
When applying the natural logarithms, 7E is estimated to be 0.00271; when not applying 
logarithms it is 10.46. Both coefficients are significant, hence, the conclusion with respect to 
steepening is the same in both cases (does not reject). The magnitudes of the coefficients are, 
however, different in the two regressions. 
With regard to the connection between red herring hypothesis (equations 6.6 and 6.7) and 
steepening (equations 6.10, 6.11 and 6.12), paper 3 concludes that the terms are independent. 
                                                          
6 Note that paper 3 estimates the growth rate )( 7E for 20 age groups (0, 1-4, …,90+). The growth rate for the age 
group 0 is suggested to be the highest (paper 3).  
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6.3 Summary of methods applied by paper 
In summary, papers 1 and 2 estimate the share of total health care expenditures used by 
decedents (6.2). Paper 1 has individual level data, while paper 2 has more aggregated data. 
Paper 1 uses descriptive statistics to estimate 6.2, while paper 2 uses regression analysis (6.8
assuming 04  E and including a dummy for each year). Furthermore, paper 2 tests the
possible endogenity of mortality in equation 6.8. The analysis fails to reject that mortality is 
exogenous in the regression. Paper 3 tests steepening by 6.10 and 6.12. To estimate 6.12
regression analyses on 6.13 was applied. Paper 4 runs a regression analysis on 6.5, assuming 
03  E (gender). In the analysis in paper 4, x is assumed to include jobs per capita, 
accessibility to hospital, and education. Furthermore, paper 4 projects future road ambulance 
expenditures by applying the estimates based on 6.5 and population predictions from Statistics 
Norway. 
Note that in papers 2 and 3, g represents a cell defined by age, gender, time and municipality,
while in paper 4 it represents municipality. 
The thesis continues with empirical results (section 7) and then discussion (section 8).
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7. Empirical results 
 
This section will present the main empirical results in this thesis, while an overview of the 
sign of coefficients estimated for papers 2–4 may be found at the end of the section in Table 
7.1. The reason not to include paper 1 in the table is that the paper is based on descriptive 
statistics and therefore does not estimate any coefficients, per se.   
Papers 1 and 2 apply data from the hospital sector and estimate the per capita hospital 
expenditures to be high for newborns and the elderly as compared to the rest of the 
population. Paper 1 uses data from 2010, while paper 2 uses data for 1998–2009. Paper 1,
based on descriptive statistics, estimates the share of the total inpatient and outpatient somatic 
hospital expenditures used by decedents (equation 6.2) to be 10.6 %, while paper 2, based on 
regression analysis on equation 6.8, estimates 6.2 to be 9.0 %.
Furthermore, both papers also find the mortality-related hospital expenditures to be declining
by age. For the non-dead (survivors), the per capita health care expenditures are high for 
newborns and elderly. Note that paper 2 ignores non-demographic factors, i.e., 4E is assumed 
to be zero. The possible impact of this simplification will be further discussed in section 8.
Papers 1-3 observe gender (q) differences with respect to health care expenditures. In the 
descriptive part of paper 2, the per capita health care expenditures for females are observed to 
be larger than those of males, for individuals less than approximately 50 years of age, with the 
exception of zero-year-olds. Conversely, the opposite is found for higher age groups.  Paper 3, 
suggest that the coefficient  3E is negative (higher expenditures per capita for males than 
females) when excluding the effect of mortality (assuming ),02  E positive otherwise. 
Paper 3 focuses on steepening (6.10 and 6.12). Equation 6.10 is estimated to be negative and 
significant. 7 When, excluding the zero-year-olds, 6.10 is estimated to be positive and not 
significant. Furthermore, 6.12 is estimated to be greater than zero if excluding the zero-year-
olds. The zero-year-olds have the highest growth in per capita health care expenditures. Apart 
                                                          
7 Applying ordinary least squares (OLS) on: 7.1 tYY tata */ 10],64,0[],106,65[ \\  
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from the newborns, the young have low growth in per capita expenditures compared to the 
elderly (50+). In conclusion, steepening is not rejected if the newborns are excluded based on
6.12.
Paper 4 applies data from the ambulance sector. The paper finds the expenditures for 
newborns and elderly to be high, as papers 1 and 2. Mortality )( 2E is found not to be 
significantly different from zero. In addition, 4E is suggested to be positive for accessibility
(short travel time to big hospital), negative for jobs per capita, and positive for low education.
With regard to the second part of paper 4, projecting future ambulance expenditures, the per 
capita expenditures are expected to decline towards 2040. There are two effects influencing 
the expenditures: 1) urbanization of the population, which decreases the costs per capita and 
2) ageing, which increases the cost per capita.
Table 7.1: Sign of coefficients by paper  
Coefficient Paper 2* Paper 3*** Paper 4***** 
Age )( 1E High for newborns 
and elderly
High for newborns 
and elderly
High for newborns 
and elderly
Mortalities )( 2E + + Not significant
Gender )( 3E
(0 if male; 1 if female)
** - or + depending on 
regression****
Other variables )( 4E
Accessibility to 
hospital
Jobs per capita
Low education
-
+
+
Age×mortalities )( 5E - -
Time )( 6E +
Time×age )( 7E + (if excluding the 
newborns)
* Dummy for each year (t) is included in the regression analysis 
**       Higher expenditures for males than females for newborns and elderly (50+)
*** The interaction between time and mortalities was also included, and estimated to be positive
**** If assuming the effects of mortalities to be zero the effect of gender is estimated to be negative, 
otherwise it is positive
***** Dummy for each ambulance district is included in the regression analysis 
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8. Conclusion and discussion 
 
According to the Grossman model, the effect of ageing on health care expenditures is 
uncertain. Several empirical papers (Colombier and Weber, 2011; Felder and Werblow, 2008)
suggest that ageing increases per capita health care expenditures. Papers 1–4 also suggest that 
ageing contributes to higher health care expenditures. Paper 3 suggests that health care 
expenditures among the elderly population are growing faster than those of the rest of the 
population. The paper does, however, mention that the literature on the underlying 
mechanisms that drive steepening is limited. Potential mechanisms will be further discussed 
in section 8.2 and 8.3.
The effect of mortality on per capita health care expenditures is suggested to be positive 
(papers 1–3); however, this is not supported in paper 4. The explanation for this rather 
unexpected result, in paper 4, may be the high correlation between age and mortality and the 
small data set applied in paper 4. The effect of age may then “mask” the effect of mortalities, 
i.e., the “multicollinerity problem” raised in the red herring debate (paper 2). Another 
explanation may be that mortality does not contribute to ambulance health care expenditures.
Furthermore, paper 2 suggests health care expenditures among females to be higher than those 
among males, apart from newborns and the elderly (aged 50 or above). In paper 3, when 
assuming the effect of mortalities to be zero  02  E , females are suggested to have lower
expenditures than males. For estimates not assuming the effect of mortalities to be zero, the 
effects of female gender are predicted to be positive. The explanation for the difference in
results in paper 3 may be that women and men have different mortality-related expenditures,
as suggested in papers 1 and 2.  
With regard to the red herring hypothesis, papers 2 and 3 reject the hypothesis that age may 
be ignored when predicting health care expenditures. The papers support the hypothesis that 
mortalities influence health care expenditures.
The remainder of this section is divided into three parts: limitations, future research, and 
finally, political implications and concluding remarks. 
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8.1 Limitations 
 
According to the Grossman model ageing is only one of several factors that influence health 
care expenditures. Christiansen et al. (2012) and Seshamani and Gray (2004) suggest that
other factors such as income may rule out the effects of age and mortality. In addition, health 
care reforms may change health care expenditures, such as implementation of new payment 
schemes or patients’ rights. Medeiros and Schwierz (2013) suggest that apart from income 
and demographic variables, other factors such as technological factors contribute to a 
substantial part of the observed growth in health care expenditures in European Union 
countries. This may require a model including more factors (x), to include potential omitted 
variables. In paper 2 we have addressed the issue of omitted variables by including dummies 
for each year, to control for unobservable time varying heterogeneity. However, it would add 
to the literature on drivers of health care expenditures to include more variables. 
In paper 4, we only have observations over a 2-year period, and applied the average over the 
two years. The short time period may result in observations that are less sensitive to 
fluctuations in omitted variables over time. The small sample (140 observations) also limits 
the amount of explanatory variables that are reasonable to include in the analysis. 
With regard to steepening (paper 3), it is defined in three dimensions (age, time and per capita 
health care expenditures) and inclusion of more variables will not, strictly speaking, test 
steepening. Applying more variables may, however, test the underlying mechanisms behind 
steepening.
With regard to the measurement of health care expenditures, papers 1–3 use DRG to estimate 
the cost. This proxy for expenditures does have limitations as discussed in papers 1–3. The 
papers mention three limitations: 1) The inflation adjustment performed to make the study 
costs comparable across years may fail to capture the rapid growth in wages in the health care 
sector in Norway; 2) the elderly in general have poorer health than the average patient with 
the same condition, hence DRG estimated costs that are equal for all age groups may 
underestimate the cost; and 3) DRG estimated costs are not the actual cost, but estimates 
based on averages.   
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With regard to 1), this would be in accordance with Baumol’s cost disease theory (Baumol, 
1993). The theory suggests that as health care expenditures increase, wages will increase more 
than productivity as the demand for health care workers increases. 
The Euro-DRG project (http://www.eurodrg.eu/) debate DRG weights ability to predict costs. 
In the project they have compared DRG-estimated costs across Europe. They conclude that 
costs vary substantially between countries for the same diagnosis. Part of the difference in 
costs is driven by different treatment procedures and wages, but part of the variation is not 
explained (Busse and on behalf of the Euro, 2012). This may imply that DRG-estimated costs 
are not representative of the actual cost of treatment, yet may represent a proxy.
To overcome the problems mentioned with regard to DRG estimates as a proxy for costs, an
alternative measure could be employed for resource use. Potential alternatives that are 
available from NPR are: Total number of days of stay in hospital or number of admissions.8
Figure 8.1 presents the two different measures for resource use per capita by age; cost 
estimated by DRG (a)) and total length of stay (b)). Comparing the figures (8.1 a)-b)) the 
different measures seems to give similar distributions across the different age groups, i.e.,
high expenditures for newborns and elderly (50+). It is beyond the scope of this thesis to
investigate this matter any further, but future research could aim at including alternative 
measures. 
For the projections portion of paper 4, the paper does not discuss the uncertainty in the 
demographic predictions from Statistics Norway. This is a limitation of the study. To illustrate 
the uncertainty, the previous population predictions from 1996 as compared to the population 
in 2013 will be presented. The main alternative population forecast from Statistics Norway 
will be applied, as applied in paper 4.
The true population in 2013 is 5 051 275, while in 1996, SSB projected it to be 
4 697 261. For the forecast in the following years (after 1996) presented by SSB, they 
systematically under-predict the population. Furthermore, the population prediction from SSB 
                                                          
8 Length of stay was only available at an aggregated level (19 regions, year, age and gender), but data at the same 
aggregated level as applied in papers 2 and 3 are available upon request if the necessary permissions are granted.  
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is fairly accurate for the first 5 years ahead of time while the deviation between actual and 
predicted population increases over time.9
Figure 8.1: Comparing different measures for resource use per capita
An alternative could be to use a stochastic population forecast such as the one presented in
Keilman et al. (2002), quantifying the uncertainty in the prediction. Here Keilman et al. 
(2002) present the population forecast with a confidence interval, indicating the historical 
variance in the variables applied in the prediction.
With regard to the analysis of the emergency services (paper 4), the paper only includes
ambulances. Other forms of transport, such as helicopters, are substitutes for road 
ambulances. Especially for long distance transport, helicopters are used to reduce traveling 
time. Therefore, excluding other forms of transport from the analysis is a limitation of the 
                                                          
9 The data was supplied upon request by Marianne Tønnesen of Statistics Norway. 
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study. However, as mentioned in paper 4, the helicopters comprise a small share of the total 
number of emergency missions as compared to road ambulances (1.6 %). 
To summarize the limitations discussed, there may be omitted variables that potentially give 
biased results; for example, health care reforms. Furthermore, DRG-estimated costs are not a 
perfect measure of actual costs and future research should ideally include other measures. The 
uncertainty in population projections is not discussed in paper 4 when predicting future health 
care expenditures. Population projections have historically been not accurate. 
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8.2 Future research 
This section summarizes and expands upon potential aims for future research within the topics 
presented in this thesis. Future research may, as previously mentioned, include: 1) the 
inclusion of additional variables (x) explaining the underlying mechanisms that induce 
steepening and health care expenditures, in general; 2) comparing different measures of health 
care expenditures; 3) including more forms of transport in the emergency services in order to 
control for the substitution effect between the different means of transport; 4) validating 
findings by using new and larger datasets to test whether mortality is still estimated not to 
have a significant effect on ambulance expenditures. A fifth target for future research, not 
previously mentioned, is to expand the discussion on the red herring hypothesis. The rest of 
this section will focus on 1) and 5). 
As acknowledged in papers 2 and 3, the methods applied in the studies are not sufficient to 
test the red herring hypothesis, as defined by Zweifel et al. (1999) (i.e., equations 6.6 and 
6.7). Karlsson and Klohn (2013) have, however, proposed techniques to test the hypothesis 
for similar data as was available and applied in papers 2 and 3. By using the probability of 
dying over a long period of time, as opposed to using only the mortality rate (the probability 
of dying within one year), they are able to estimate a proxy for time to death on aggregated 
data, subsequently enabling them to test the red herring hypothesis. They defined time to 
death as the probability of dying within the next two years. Expected time to death for age 
group a in year t is determined by: the probability of dying within the time period (t), the 
mortality rate for the age group in year t ),( ,tam and the mortality rate for the next time period 
for the same cohort ).( 1,1  tam
Time to death (TTD) for age (a) and time (t) is then estimated to be:
8.1 )1()1(1 1,1,, u tatata mmTTD
By utilizing this approach, Karlsson and Klohn (2013), suggests that one may test the red 
herring hypothesis on similar data as applied in papers 2 and 3. This may be a potential target
for future research.   
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Mechanisms inducing steepening  
As mentioned in paper 3, the literature on mechanisms inducing steepening is limited. The 
paper states on page 3 that:
“In summary, the literature on the causes of increased expenditures for the elderly 
indicates that there might be a technological bias and changes in biological factors 
(morbidity). With regard to the first, the technological bias is likely to be driven by
some underlying mechanism that is poorly explained in Felder and Werblow (2008).
One reason might be biological changes over time, but there could also be other 
mechanisms driving steepening.”
The following section proposes that a major mechanism driving steepening is increased health 
care expenditures and rational behavior. To the best of my knowledge this hypothesis has not 
previously been presented. The model presented is limited, and a future research target should 
be to expand this model.
 
Health care expenditures and steepening; a simple theoretical model 
 
To illustrate the hypothesis, I will build a simple model using only two individuals, old (O) 
and young (J) and two types of health care services, A and B. 
The older consumer is assumed to have a wider range of healthcare needs (diseases or 
dysfunctions) than the younger, and hence uses a wider range of health care services. Further, 
it is assumed that category A services (A1,…,Am) are relevant for both the old and young, 
while services in category B (B1,…,Bn) are only relevant for the old. Category A includes 
services like emergency care and simple procedures, while category B services include more 
complicated procedures. Another way of interpreting the assumption is that the older 
individual has multimorbidity conditions requiring advanced care, while the younger has 
“simpler” conditions, “monomorbidity”. 
a denotes the monetary investment in A services, while b is the monetary investment in B 
services. Furthermore, the amount of A services consumed by the young is denoted by aJ,
equivalent for the old, aO.
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Utility for the old from health care expenditures is the sum of health care expenditures in A 
and B services: 
8.2 )()( ,, bUaUU OBoOAO  
Utility for the young:
8.3 )(, JJAJ aUU  
Furthermore, the social planner is assumed to maximize the sum of utility for the old and 
young. The old and young consumers are assumed to have strictly increasing utility from 
investments in A services, but decreasing marginal utility:
8.4 0/ !ww iA aU , 0/2 www iiA aaU ^ `OJi , 
Furthermore, it is assumed that the marginal utility for the old consumer from investments in 
B services is low.  More specifically, it is assumed that below a certain threshold the marginal 
utility from investments in B services is lower than investments in A services. Above this 
threshold it is assumed that the marginal utility from investments in B services is higher than 
investment in A services: 
8.5
b
U
a
U OB
i
iA
w
w!w
w ,, for   Ti Ya  ^ `OJi , 
8.6
b
U
a
U OB
i
iA
w
ww
w ,, for   Ti Ya ! ^ `OJi , 
8.7
b
U
a
U OB
i
iA
w
w w
w ,, for    Ti Yab   ^ `OJi , 
The interpretation of equations 8.5–7 is that the society prefers to employ simple procedures 
before they deliver more complicated procedures, i.e., “triage” health care prioritization. For 
example, they first deliver vaccines and basic emergency care (type A services), before 
offering more complicated procedures such as complex cancer treatment (category B 
services). Another example of B services could be treatment at an intensive care unit in a 
hospital for multimorbidity. 
Furthermore, total health care expenditures in the society are exogenously determined and 
denoted by Y*. The budget constraint is then given by:
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8.8 Y*=aJ+ao+b
The utility for the society is assumed to be the sum of utility for the old and young. The social 
planner will then maximize the sum of the utility for the old and young subjects against the 
budget constraint:
8.9 ^ `)()()( ,0,,0,, bUaUaUUUMax OBOAJJAJbaa OJ  
subject to  8.7
The marginal utility for investments in A services for the young and old is higher than 
investments in B services below Ti Ya  (equations 8.5-7), hence the social planner will only 
invest in A services if the total health care expenditures are below 2YT. For total expenditures 
above 2YT, the social planner will invest Y*-2YT in B services.    
In conclusion, for total health care expenditures Y*< 2YT, the share of total health care 
expenditures consumed by the old are not determined in the model, and above the share 
increases with increased expenditures. 
Steepening is characterized by a situation where the share of total health care expenditures 
consumed by the elderly is increasing over time. According to the definition presented by 
Buchner and Wasem (2006) (6.11) steepening is defined by:
8.10
1,
11,
,
,

 !
tJ
ttO
tJ
ttO
a
ba
a
ba
, where t is time
In figure 8.1, the share of total health care expenditures consumed by the old is presented. In 
this figure the solid line indicates the share of total health care expenditures consumed by the 
old, above total health care expenditures of 2YT. In conclusion, the model predicts that for 
countries with high health care expenditures, steepening will be present in periods of 
increased health care expenditures. For countries with low health care expenditures, the model 
is inconclusive with regard to steepening.
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Figure 8.1 Distribution of health care expenditures between young and old
2YT                                                                                            
All the papers presented in the section 2.1 apart from Seshamani and Gray (2002) and Felder 
and Werblow (2008), find that an increasing share of the total health care expenditures is 
devoted to elderly. The papers, therefore, support steepening—hence our theoretical model—
apart from Seshamani and Gray (2002) and Felder and Werblow (2008). With regard to the 
data that forms the empirical part of paper 3, we should observe steepening according to the
hypothesis, as we observe strong growth in health care expenditures per capita in the 
observation period. Paper 3 therefore does not reject the hypothesis.
It is beyond the scope of this thesis to test the hypothesis any further, but the reduced per 
capita health care expenditures in Iceland for the past years may be compared to Norwegian 
data as a good case to test the hypothesis. Furthermore, future research should expand the 
discussion regarding the functional form of UA and UB.
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8.3 Policy implications and concluding remarks  
 
For hospital services, papers 1–3 suggest that the effect of both age and mortality have a 
positive impact on per capita hospital expenditures. This implies that solely including age 
when predicting future health care expenditures gives biased results. The simple method is 
also referred to as the naïve approach (Häkkinen et al., 2008). The naïve method may be 
illustrated by 8.11 and was applied in, among others, Waaler (1999). This method assumes 
that the total health care expenditures (Y) t' years from year t are dependent on per capita 
expenditures for each age group today, multiplied by the number of inhabitants in different 
age groups in the future:
8.11 ¦ ''  
a
ttatatt nYY ,,
Papers 1–3 suggest that this approach will lead to biased results, as it does not distinguish
between expenditures associated with end of life and non-end of life expenditures. As the 
papers propose, a substantial share of health care expenditures rise during the last year of life. 
A model that can be used to predict future health care expenditures that distinguish between 
these costs is therefore more appropriate. Equation 8.12 illustrates how this may be taken into 
account by drawing an explicit distinction between the health care expenditures for decedents 
(d) and survivors (s):
8.12 ¦ ¹¸·©¨§  ''' a
d
ta
d
tta
s
ta
s
ttatt YnYnY ,,,,
Based on Melberg et al. (2012), which provided the inspiration for paper 3, the Norwegian 
Ministry of Finance altered the predictions of future health care expenditures from equation 
8.11 to 8.12.
The empirical results in paper 3 suggest that the mortality-related expenditures are estimated 
to increase over time (the interaction between time and mortality is positive) even though life 
expectancy increases. With regard to the shift hypothesis presented in, among others, Melberg 
and Sørensen (2013), this result is interesting, as the result indicate movements in mortality 
related expenditures over time. 
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With regard to ambulances, we find the effect of mortalities to be non-significant, implying 
that 8.11 and 8.12 give equivalent results when predicting future expenditures. As mentioned 
earlier, one should, however, interpret the results with care due to the small dataset and high 
correlation between age and mortalities. Regardless of the sign of 2E (mortalities), predictions
of future ambulance expenditures are relevant for the ongoing debate surrounding the 
centralization of hospitals in Norway. The arguments which support centralization include 
better trained and specialized medical personnel and economic gains. Conversely, 
centralization of hospitals will increase the travel distance for some patients and subsequently 
increase the travel distance for ambulances. This thesis suggests that per capita expenditures 
for road ambulances will decrease due to urbanization and increase due to ageing towards 
2040. In addition, the expenditures are suggested to be higher for newborns than for children 
and young adults (paper 4).
With regard to steepening in developed countries and assuming the hypothesis presented in 
the Future Research section holds, we can expect to observe steepening in periods of 
increased per capita health care expenditures, and bias towards younger age groups in periods 
of reduced per capita health care expenditures. Numerous empirical papers (see, among 
others, Getzen (2000)) suggest that when income increases, the investments in health care 
expenditures also increase. Therefore, in periods of economic growth, it is reasonable to 
predict that steepening will be present, assuming that the theoretical model is correct.
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Key results 
 
In Norway, between 9 and 10.6% of total hospital expenditures are allocated to decedents
within one calendar year. Paper 1 uses data from 2010 and suggests the share to be 10.6% (in-
and outpatient care), while paper 2 uses data from 1998–2009 and suggests the share to be 
9.0% (inpatient care). Furthermore, our analysis suggests that mortality-related hospital 
expenditures are decreasing as a function of age (papers 1–3).  
With regard to steepening, this thesis suggests that this phenomenon was present in Norway 
from 1998 to 2009 within the hospital sector (paper 3). Furthermore, the terms red herring 
hypothesis and steepening are found to be independent. 
Based on the theoretical model presented, one should expect to observe steepening in
countries with high health care expenditures per capita in periods of increased per capita 
health care expenditures, and biased towards younger age groups in periods of reduced
expenditures per capita.  
Furthermore, for ambulance services the expenditures are dependent on travel time to hospital 
and age (paper 4). Our predictions for 2040 suggest that the expenditures for ambulance 
services will decrease due to urbanization, but increase due to an increased share of elderly 
individuals—resulting in an overall decline in the expenditures per capita.
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MAIN MESSAGE
More than 10  % of total hospital expenses 
for somatic outpatient and hospital treat-
ment in 2010 were spent on patients who 
died within the same year.
Hospital expenses associated with patients 
in their final year of life increased consider-
ably during the three months prior to their 
death.
The average expenses for hospital treat-
ment of persons who died in 2010 declined 
with increasing age.
BACKGROUND International research indicates that a considerable proportion of health 
expenditure is concentrated in the final phase of life, but to date, reliable Norwegian figures 
have not been available in this area. The purpose of this study is to investigate the proportion 
of Norwegian hospital expenditure for outpatient and hospital treatment which is devoted 
to persons who die in the course of the year.
MATERIAL AND METHOD To estimate the proportion of hospital resources devoted to treat-
ment of patients who die in the course of the year, we use data from the Norwegian Patient 
Registry, which contains information on all individual treatment episodes of outpatient and 
hospital treatment in the period 2010, and information from the National Resident Registry 
on deaths that have occurred during the same year.
RESULTS In total, NOK 4.2 billion, or 10.6  % of all hospital expenses for outpatient and hos-
pital treatment in 2010, was devoted to patients who died during the same year. The bulk 
of the expenses was incurred during the three months immediately prior to death. Hospital 
expenses towards the end of life declined with increasing age of the patient, and were more 
than halved for ninety-year-olds compared to seventy-year-olds. More than 50  % of the 
expenses incurred during the last year of life were spent during the three final months of life.
INTERPRETATION These results are relevant for estimating future hospital expenses 
in the health services. They are also relevant for decision-making related to priorities, 
but the figures for expenses cannot be used to determine whether too much or too little is 
spent on a given age group or disease.
Several international studies show that a
considerable proportion of health expenses
are spent on treatment in the final phase of
life, but the estimates vary greatly (1–6).
Some of this variation occurs because the
studies have different time frames, include
different expenses and consider different
groups of patients. A study by Polder and
collaborators of expenses in the Netherlands
shows that 11 % of all health expenses are
devoted to patients in their final year of life
(6), but do not include expenses for psych-
iatry. In their study from Finland, Häkkinen
and collaborators include hospitals, psych-
iatry, drugs and other expenses, and con-
clude that 14% of the expenses are devoted
to patients in their final year of life, but they
focus only on those aged over 65 (1). On the
basis of data from Medicare, which largely
include people aged 65 and above, studies
from the USA show that 25–33 % of the
expenses for this group are incurred by
patients in their final year of life (7–10).
In Norway, we have a vibrant and impor-
tant debate on treatment at the end of life
(11–13), but we have little knowledge about
the costs involved. The only Norwegian
study available estimates these costs to be
18–26 % of the total (14), but the study is
now more than 20 years old and based on
estimates, since individual data were
unavailable at the time. The literature is thus
characterised by studies that are based on
various components of expenditure for dif-
ferent periods of time in various sub-groups,
and include results that are based on esti-
mates. Using data from the Norwegian
Patient Registry, many of these problems
can be avoided. We can calculate hospital
expenditure on the basis of individual data
for the entire population, and we can esti-
mate the real average hospital expenses for
men and women who died in 2010 and for
those who lived through the entire year.
Material and method
The results in this report are based on a data
set in which information from the National
Resident Registry identifying which persons
died in 2010 and which survived, was linked
to data from the Norwegian Patient Registry.
The data set comprises 1 294 626 contacts
with hospitals, distributed among 729 887
patients. For each of these individuals, we
have information telling us whether he or
she survived or died in 2010, and his or her
use of hospital services in the form of out-
patient or hospital treatment. The linkage of
the registries was undertaken by the patient
registry. Many individuals had more than
one treatment episode, but with the aid of the
personal identifier in the Norwegian Patient
Registry we were able to total up costs at the
individual level. The data set contained
© Copyright Tidsskrift for Den norske legeforening.
Reprint not allowed. Downloaded from www.tidsskriftet.no 17.12.2013
842 Tidsskr Nor Legeforen nr. 8, 2013; 133
ORIGINAL ARTICLE    
27 341 patients who had died in 2010 and
who had undergone outpatient or hospital
treatment for which costs had been registe-
red in the same year.
The average cost per person who died in
each age group has been calculated by
dividing the total hospital costs for persons
who died in a given age group in 2010 by the
total number of persons who died in Norway
as a whole in the same age group. The aver-
age cost per person who survived 2010 has
been calculated in the same manner. Our
figures thus represent the average cost per
person in the age group as a whole, not only
the average cost for those who received
treatment. Information on the number of
deaths and survivors in various gender and
age groups was retrieved from Statistics
Norway. The calculation of costs was based
on the assumption that a treatment sequence
for various diagnostic groups has an average
cost indicated by its DRG weight.
Results
Of those who died in 2010, altogether
27 341 (65%) had visited a hospital for
some form of cost-accounted outpatient or
hospital treatment during the same year. The
total costs for those who died amounted to
NOK 4.2 billion, i.e. 10.6% of the total hos-
pital costs devoted to somatic outpatient or
hospital treatment recorded by the DRG sys-
tem. Figure 1 shows the proportion of hos-
pital costs in various age groups that were
devoted to persons who died in 2010. This
proportion rises with age: Of all resources
spent on people in their fifties in hospitals,
7 % were incurred by persons who died in
the course of the year. For people in their
seventies the corresponding proportion
amounted to 13%, for patients in their
eighties it was 19% and for those in their
nineties it amounted to 29 %.
Figure 2 shows average hospital costs for
outpatient and hospital treatment in various
age groups over 50. For example, the dia-
gram reveals that women aged 70 who died
in 2010 on average received hospital treat-
ment worth NOK 157 000 in that year, while
the average for those who lived through the
entire year amounted to NOK 16 000. The
excess cost for those approaching the end of
life thereby amounted to NOK 141 000, and
the hospital expenses for women in their
seventies who died in 2010 were close to ten
times higher than for women who lived
through all of 2010. The figure also shows
that the costs for those who died decreased
with age, while the costs for those who sur-
vived 2010 increased with age.
Figure 3 shows the monthly percentage
distribution of the total hospital expenses for
the last year for men and women in their
eighties who died in December 2010. The
data set contained 3 096 persons who died in
December. Of these, altogether 102 persons
were over 80 years of age, and for this group,
a total of 868 cost-incurring hospital con-
tacts had been recorded. Of all the expenses
incurred during the last year before death,
30 % were incurred during the final month
and more than 50% during the final three
months. This pattern could also be identified
in other age groups (e-Table 1).
Discussion
The results show that the total expenses asso-
ciated with hospital treatment of persons
who died in 2010 amount to 10.6 % of total
hospital expenditure, but that the average
expenditure per person decreased with age
(Figure 2). Hospital expenses for women in
their eighties who died in 2010 were on aver-
age more than NOK 50 000 (33%) lower
than for seventy-year-olds who died in the
same year. Corresponding figures for men
were a decrease of NOK 40 000 (24%). The
figure also shows that more resources were
spent on women than men who passed away
at a relatively young age (under 60 years
of age), while more was spent on men who
passed away at an older age (over 80 years
of age).
There are several reasons why expenses
vary with gender and age. First, studies
show that those who die at an early age often
succumb to diseases or injuries that require
more hospital resources than those who die
in old age (15). For example, many die from
cancer at a relatively young age, especially
women, whereas people in older age groups
more frequently die of a myocardial infarc-
tion (16).
International research in this area indicates
that one cannot explain the entire difference
between the age groups in terms of the preva-
lence of diseases or events; some of it may
also be due to the fact that identical diseases
are not treated as aggressively in older age
groups (17–19). There may be sound medi-
cal reasons for this, since elderly patients are
unable to sustain the same tough treatment as
younger patients, although the literature indi-
cates that elements of age discrimination may
also be involved (16, 18). Further studies are
required to clarify this.
The variations between consecutive age
cohorts illustrate the impact of historical and
institutional issues. For example, health and
expenses may be influenced by retirement or
by having been born into an age cohort that
has experienced particular events or epide-
mics. In addition to random variations, such
issues illustrate why the expenses do not
follow a straight decline, but vary around
a decreasing trend at different age levels.
A potential problem associated with
investigating hospital expenses for those
who died in a particular year as opposed to
those who lived through the entire year is
that one fails to capture all death-related hos-
pital expenses: If the costs associated with
the cause of death are spread over several
years, the investigation will be biased if only
hospital expenses in the current year are
included. In the data set, this applied in par-
ticular to those who died early in 2010,
where the hospital expenses most likely had
increased from late 2009. A key issue is the
extent to which the costs were incurred at the
very end of life, or whether they were more
evenly distributed over a short or long period
prior to death. This is illustrated in Figure 3,
Figure 1  Proportion of hospital expenses registered in the DRG system for outpatient and hospital treatment 
incurred at various age levels and devoted to patients who died during 2010
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which shows two clear trends: First,
expenses increased slowly towards the time
of death. In analyses of data from the UK, a
slight increase could be found as far back as
15 years before death (3). This could indicate
that the definition of death-related expenses
ought to be expanded. Second, the analysis
of our material shows that even though the
costs increased long before the time of death,
this increase was minor compared to the
increase in expenditure during the last few
months. Hospital expenses accrued during
the final month accounted for 30 % of all
costs over the year for persons who died in
December. Among patients in their eighties,
the final three months prior to death accoun-
ted for 50 % of the total cost. We found a
similar pattern for the other high-age groups.
We may therefore assert that even though
hospital expenses start increasing for some
time prior to death, the bulk of the cost is
incurred during a short period at the very end
of life.
As a whole, this means that the figures
probably capture a considerable proportion
of the hospital expenses associated with the
disease that caused death, but that the sum
would have been greater if we could have
obtained an overview of all death-related
hospital expenses over several years. At the
same time, by extending the time frame we
would also run the risk of including treat-
ment expenses that were unrelated to the end
of life. For example, not all costs of treat-
ment in January will necessarily be related
to the cause of death if the patient dies in
December. The correct interpretation of the
figures is therefore «hospital expenses asso-
ciated with persons who died in 2010», and
that this represents a cautious, but not
unrealistic, estimate of «hospital expenses
towards the end of life».
The observation that large hospital costs
are incurred by patients towards the end of
their lives has major implications for the ex-
trapolation of health expenditure. Assuming
an increase in life expectancy, a traditional
extrapolation of hospital expenses involves
multiplication of the current average cost in
various age groups with the number of
people expected in these age groups in the
future (20, 21). A problem associated with
this method is that it fails to distinguish
between expenses associated with the period
prior to death, irrespective of age, and the
expenses that follow from age alone.
Today’s average expenses for people in their
seventies include the costs of the many who
die at age 70. If life expectancy rises, the
proportion of people who die at age 70 will
decrease, and the age-related average
expenses for people in their seventies will
thus also decrease. A more correct extra-
polation of expenditure levels should take
this into account.
A possible limitation of the analyses can be
found in the use of DRG weights as a
measure of expenses. In reality, some patients
Figure 2  Average cost registered in the DRG system for somatic hospital treatment of persons aged over 50. 
The costs are distributed on those who died in 2010 and those who survived, as well as by age and gender
300 000
250 000
200 000
150 000
100 000
50 000
0
NOK
Age
50 60 70 80 90 100
 Men, living       Women, living       Men, deceased        deceased ,Women
Figure 3  Total registered costs for hospital treatment during the last year of life, percentage distribution 
by the last 12 months prior to death for all patients in their eighties who died in December 2010 and received 
hospital treatment in 2010 (n = 102)
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will cost more and others less than the DRG
rate. If it costs more to treat a patient in her
final year of life than another patient with an
identical diagnosis and DRG category, the
use of DRG rates will underestimate the costs
associated with the end of life. There is also
the possibility of an opposite bias: That the
treatment of patients with the same diagnosis
costs less when the patient is in her final year
of life and unable to sustain similarly aggres-
sive treatment. In this case, the DRG rates
will overestimate the costs.
The finding that approximately 10% of
all hospital expenses were devoted to
patients who died in the course of the year
should be treated with some caution in the
context of prioritisation. This requires
another approach, investigating the extent to
which the quality and length of life increase
for those patients who receive hospital treat-
ment in what could potentially be their last
year of life. While some of these patients
will die, many others will have a longer and
better life as a result of the treatment. More-
over, many of those who die will have an
enhanced quality of life as a result of hos-
pital treatment in the period preceding their
death. We have only investigated one half of
this assessment, the costs, and can conclude
that the costs associated with patients who
die in the course of a year account for
approximately 10 % of all hospital costs and
vary somewhat according to gender and a lot
according to age.
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Abstract: The aim of this paper is to contribute to the debate on population aging 
and growth in health expenditures, by providing estimates on how mortality 
related expenditures are influenced by age. Using a register of inpatient hospital 
admissions to create gender-cohort specific panels for each of the 430 Norwegian 
municipalities, we are able to identify mortality related hospital expenditures by 
separating the impact of mortality on current hospital expenditures from the 
impact of patients’ age and gender. We apply model estimates to quantify the 
mortality-related hospital expenditures for twenty age groups. Our results, which 
rely on the assumption that mortalities are exogenous in the empirical 
specification, suggest that mortality-related hospital expenditures are a decreasing 
function of age. Furthermore, the results imply that, both age and mortalities 
should be included when predicting future health care expenditures. The 
estimation results suggest that 9.0 % of all hospital expenditures are associated 
with treating individuals in their last year of life. Our results also suggest that the 
reduction in mortality rates in the period from 1998 to 2009 have, cet. par. 
contributed to an estimated reduction in total hospital expenditures of 0.6 billion 
NOK, a difference corresponding to 2 % of the expenditures in 2009. 
 
JEL codes: I11, I12, I19, H51 
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1 Introduction and background 
In early applications, a population’s health care expenditures were commonly modeled as 
a function of basic demographic characteristics, such as age and gender. This approach 
applies the well-known fact that different age and gender groups have different health care 
needs. Using estimates of each group’s per capita expenditures, so-called naïve predictions 
of the population’s future health care expenditures can be computed based on future 
demographic characteristics. 
 This naïve approach was challenged by researchers who suggested that the 
expenditures are related to mortalities. In the seminal article by Zweifel et al. (1999) the   
204 Nordic Journal of Health Economics 
 
 
authors hypothesized that time to death is more important than age in predicting future 
health care expenditure, and this hypothesis is frequently referred to as the Red Herring 
Hypothesis. Applying data on health care expenditures for inhabitants above 65 years of 
age in Switzerland, they found evidence supporting the Red Herring Hypothesis.  
More than 30 papers (see among others Salas and Raftery (2001), Zweifel et al. 
(2001) and Felder et al. (2010)) have been published in the Red Herring debate and there 
appears to be strong evidence suggesting that both age and time to death are factors 
influencing health expenditures, even though the relative importance of age and time to 
death is strongly debated. In Colombier and Weber (2011) it is stated that  “time to death 
is of marginal importance”, while other studies, Werblow et al. (2007) and Zweifel et al. 
(2004), claim the opposite; age is of marginal importance. An aspect that has received less 
attention in the literature is that the costs that are incurred as a result of proximity to death 
may depend on the age of the individual. In a study of hospital expenditures for elderly 
decedents in the United States, Levinsky et al. (2001) found that expenditures decreased in 
age for elderly decedents, and similar findings were also reported by Häkkinen et al. 
(2008) and Melberg et al. (2013). If expenditures associated with the last year of life are 
substantially influenced by age, this implies that increasing longevity and postponing 
death until a higher and less costly age, will contribute to slower growth in health 
expenditures.1  The aim of this paper is twofold. Firstly, we aim to quantify the impact of 
age on mortality related expenditures. Secondly, we aim to assess the influence of 
changing longevity on hospital expenditures that occur as death is postponed to higher 
ages where mortality related expenditures are lower. 
By estimating the relationship between mortality related expenditures and age, we 
also contribute to the Red Herring debate. If there are large variations in the mortality 
related expenditures by age, including only time to death and not the interaction between 
age and mortalities, will yield upwardly biased results when predicting future health care 
expenditures. 
There are several studies (see among others Häkkinen et al. (2008), Emanuel 
(1996) and Lubitz and Riley (1993)) that present the relationship between age and 
mortality related expenditures, but the studies only include the elderly part of the 
population. This paper includes all ages. This is important as the mortality related 
expenditures among younger individuals also contribute to the total health care 
expenditures. 
Here, we apply data from the Norwegian Patient Registry (NPR) merged with 
demographic data from Statistics Norway (SSB). An advantage of this study, compared to 
previous studies is that there is no self-selection into our data. This makes the study 
unique. The data set follows Norway’s population (5 million inhabitants) over a 12 year 
period from 1998-2009, and we are thus able to assess how the change in longevity over 
the 12-year period has influenced the expenditures. 
The paper proceeds as follows: The study setting is described in the next section 
(Section 2). In Section 3 we describe the data. Our empirical specification and estimation 
results are presented in Section 4. Finally, in Section 5 we conclude and discuss the 
findings. 
 
 
                                                
1 In addition, length of life increases may, as suggested by Madsen (2004) and Breyer and Felder (2006), 
influence the morbidity patterns for different ages. It is beyond the scope of this paper to investigate this any 
further. 
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2 Study setting 
The current organization of the health care system in Norway has many similarities to 
those in other Nordic countries and the United Kingdom (UK); hospital services are 
mainly provided by public health institutions, which are financed through general taxation. 
In Norway, hospitals are governed from the central government by the Ministry of Health, 
while the general practitioners (GP) and dentists practice privately and contract with the 
local level of government (municipality and county). At present, the hospital sector in 
Norway is divided into four Regional Health Enterprises (RHEs) which correspond to 
geographical areas. Each region receives funding based on per capita funding (60%) and 
activity based financing (ABF) (40%). ABF is based on the diagnosis related groups 
(DRG) system (Kalseth et al., 2010). ABF was introduced in June 1997. Note also that the 
share paid by per capita funding has varied from 1997 until today (Carlsen, 2008). 
There is no out of pocket payment for public in-patient hospital services in 
Norway.2 The GPs act as gatekeepers for hospitals with an exception of emergency cases, 
where the ambulance staff or other medical personnel may assign patients directly to the 
hospital (Johnsen and Bankauskaite, 2006). Patients may choose which hospital he/she 
would like to be treated at for elective care. 
3 Data  
3.1 Structure of the data 
Two data sources are used in this study: Cost information for hospital admissions are 
extracted from the NPR and demographic data from SSB. The data from NPR provide a 
registry of all in-patient hospital admissions in Norway from January 1998 to December 
2009. Registration in NPR is compulsory for all hospitals and each admission to the 
hospital is registered as one observation. It is not possible to track individuals across 
different hospitals, or different years. A total of 14.5 million admissions were recorded in 
the given time period, and the included patients are residents of all 430 different 
municipalities in Norway.  
We apply five variables from the database; year of birth, gender, year of hospital 
stay and the number of DRG-points. Since we cannot identify individuals, we cannot link 
individual mortalities to hospital stays. We therefore aggregate the data to the smallest 
possible group where observed mortalities can be linked to observed hospital 
expenditures, and that is to groups formed by age-gender-specific groups in each 
Norwegian municipality. From SSB we received, for each year, data on the number of 
individuals belonging to each of these groups as well as the number of mortalities. 
Aggregation was performed by grouping the data, and each group was uniquely 
characterized by a realization of the set of categorical variables age (Ai ), gender (Gi ), year 
(Ti ) and municipality catchment area (Ri ). The variable Ai takes 101 discrete values in the 
range [0,100], the variable Gi takes two possible values, male or female. Since we have 
observations from 1998 to 2009 Ti takes 12 unique values. There are 430 municipalities, 
and hence, R takes 430 unique values. In total there are 101*2*12*430=1,042,320 unique 
groups formed by different combinations of , , ,i i i iA G T R . 
We index the groups by g and we let Ng denote the number of individuals 
belonging to group g. By computing the total cost of hospital services within the group 
                                                
2  There are a few exceptions, and on rare occasions individuals pay out of pocket for in-patient hospital care 
that is not covered by national insurance. Such payments amount to less than 0.4 % of total expenditures for 
secondary care (Samdata, The Norwegian Directorate of Health, 2012). 
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and dividing by the number of persons in each group, we get a per capita measure of 
hospital expenditures for each group. If we denote the expenditures associated with 
individual hospital admissions by Yi , an expression for the per capita expenditures in 
group g, denoted by  is given by: 
 
 
     
3.2 Descriptive statistics 
We now provide an overview of the data. Throughout the rest of this paper we measure 
the expenditures in Norwegian Kroner (NOK) inflation adjusted to 2010 NOK.3,4 In Table 
1 we present the development of demographic characteristics in the period. We observe 
that although both the general population and the number of elderly older than 64 has 
increased during this period, the total number of mortalities has been reduced. We also see 
that the share of the population above 64 years of age has stayed stable at around 16 %.  
 
Table 1: Demographic characteristics 
 
Year 
 
Number of inhabitants age >64 Total mortalities Number of inhabitants Share age >64 
1998 718463 44119 4436605 16.2 % 
1999 714455 44956 4465158 16.0 % 
2000 709488 43930 4498328 15.8 % 
2001 706532 43837 4520531 15.6 % 
2002 705181 44268 4543897 15.5 % 
2003 704553 42517 4573057 15.4 % 
2004 706575 41280 4598770 15.4 % 
2005 711357 41250 4628668 15.4 % 
2006 716590 41416 4676098 15.3 % 
2007 725038 42158 4716808 15.4 % 
2008 739870 42139 4797661 15.4 % 
2009 757259 41659 4861059 15.6 % 
2010 777056 42025 4919639 15.8 % 
 
 
In Table 2 we describe the characteristics of the group structure in the data. The average 
group includes 56 individuals. We observe that there is large variation in group size. The 
smallest group includes only one individual, whereas the largest group includes 6699 
individuals. We also characterize the group level per capita expenditures and the group 
level mortality rate. We observe that the group level per capita expenditures range from 
zero to more than one million NOK whereas the group level mortality rate ranges from 
zero to one. 
                                                
3 8 NOK=1 EURO and 6 NOK=1 USD (2010) 
4 The price level in the health care sector has grown faster than for the rest of the economy, therefore 
consumer price inflation adjustment may not be sufficient to isolate the changes in use of resources over 
time.  
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Table 2: Descriptive statistics of group level variables 
Variable 
Number of 
observations Mean Std. Dev. Min Max 
Number of individuals  
in group Ng  
995158 56 183 1 6699 
Group level per capita 
expenditures a 
    .
 995158 10454.79 17153.82 0 1006657 
Group level mortality rate  
    .
 995158 0.0341476 0.1229989 0 1 
a The expenditure reported in the table is the expenditure related to activity (patient treatment) and not other costs such as 
pension costs in the health enterprises. The number is therefore lower than the cost reported in OECD and Norwegian 
Ministry of Health for inpatients in somatic care. 
 
 
Furthermore, figure 1 describes per capita hospital expenditures for males and females. 
The expenditures are high for newborns and people above 60 years of age. The 
expenditures for women are clearly higher than males in the childbearing years (i.e. 
between the age of early twenties and late thirties), while males have higher expenditures 
for the ages above 50. 
 
Figure 1: Hospital expenditures per capita measured in NOK by age, 1998-2009 
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4 Estimation and results 
Our aim is to quantify the mortality related expenditures in a situation where mortalities 
are only observable at a group level. We aggregate our data to obtain data in a format 
including observable variables at group level which still enables us to identify the effect of 
mortalities on hospital expenditures at the individual level. To do this, we let Yi refer to 
individual i’s total hospital expenditures in a given year. We assume a linear regression 
function, relating these expenditures to observable characteristics: 
 
1) 0 1 2i i i iY X D u  = + + + , iu ~ ( )2,0 iid  
 
where 1 and 2 are a vectors of unknown parameters to be estimated and 0 is an unknown 
scalar parameter to be estimated. The matrix Xi is a matrix of dummy variables capturing 
the effect of age and gender, including interaction terms. We distinguish between 20 
different age groups in our regression model, infants and children aged 1-4, and we also 
categorize age in 5 year intervals until age 85-90. Individuals older than 90 are grouped 
together. The variable Di is an indicator variable equal to one if the individual i died 
within the year. This variable is not observable due to the fact that we may not link current 
or future mortalities with hospital admissions; hence, estimating 1) is not feasible. 
However, the number of mortalities within each group each year,  , is observable 
and included in our data. Thus, we may estimate the impact of mortalities in each group 
on the group level hospital expenditures. If we index groups by g, and let Ng denote the 
number of observations in group g, we may express a regression equation where only 
observable variables are included, and where we may identify and estimate the unknown 
constants from 1): By summing over i on each side of 1) and dividing by Ng, equation 1) 
can be written based on the group means from each year: 
 
2) [ ] [ ]0 1 2
1 1
i i i i
i g i gg g
Y X D u
N N
  
 
= + + +   
Applying the notation 


gi
i
g
g Y
N
Y 1  we may write 2) as 
3) 0 1 2g g g gY X D u  = + + +  
We note that the error terms in equation 3) are heteroscedastic, due to variation in the size 
of the groups, Ng.  
One may argue that the mortality rate for each age group may be endogenous, and 
partly influenced by the health expenditures. However, one may argue that the potential 
simultaneity bias is likely to be small when analyzing Norwegian data, as Norway offers 
universal health insurance and full coverage for the whole population and the health care 
spending is high. The life expectancy at birth in Norway in 2011 was 79 years for males 
and 83.5 for females according to Statistics Norway. This is among the highest in the 
Organization for Economic Co-operation and Development (OECD), and one may argue 
that the marginal effect of hospital expenditures in terms of higher group level survival 
within the given year is likely to be very small for Norwegian patients.  
However, we test the assumption that mortalities represent an exogenous variable in 
equation 3) by means of a Wu-Hausman and a Durbin test: We use the mortality rate in 
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year t-1, as an instrument for the mortality rate in year t. The mortality rate in year t-1 is 
likely to be correlated to the mortality rate in year t; however, it is clearly not a function of 
the health care expenditure in year t. We run two stage least squares (2SLS) and test the 
assumption that mortalities are exogenous. Based on the tests we cannot reject the null 
hypothesis that mortalities are exogenous (both tests with a p-value=0.9). The tests were 
performed on 3) with instruments; the 2SLS regression may be found in the appendix 
(Table A.1). 
For the rest of the analysis, we will assume that we may treat mortalities as 
exogenous. Furthermore, we apply a Wooldridge test for serial correlation in panel data 
models, and the null hypothesis of no serial correlation is rejected in favor of a regression 
model with a first order autoregressive process (AR1) in the error terms (p=0.00). The test 
was performed on 3). The test results indicate that appropriate modeling and estimation 
should take both serial correlation and heteroscedasticity into account. We estimated 3) 
taking into account the AR1 process in the error terms, and the results from estimation is 
presented in Table 3. The resulting standard errors of the estimates were slightly larger 
compared to the results from a model estimated by means of weighted least squares 
(WLS) under the assumption of no serial correlation. The results for WLS regression 
assuming no serial correlation may be found in the appendix (Table A.2).  
In Table 3a we observe that all the estimated coefficients for both age and 
mortalities are significant. The estimated coefficients are also statistically significant when 
excluding mortalities (Table 3b), a model referred to as the naïve approach in Häkkinen et 
al. (2008). 
Based on the regressions presented in Table 3a, we may now describe how 
mortality related hospital expenditures (MRE), defined as the estimated marginal effect of 
mortalities on hospital expenditures, depend on age. In Figure 2, we present the 
relationship between age and MRE. We observe that MRE is highest for the age groups 
below 60 and declines sharply for the older age groups. We also observe that female 
decedents have a larger MRE than males until the age of 75, while after the age of 75 male 
decedents have the largest MRE. This is in accordance with the findings in Melberg et al. 
(2013). 
Furthermore, Figure 3 presents estimated increase in per capita health care 
expenditures by age excluding the effect of mortalities, based on the regression results 
presented in Table 3a. The figure shows that the health care expenditures for newborns 
and elderly are high compared to the rest of the population. Furthermore, the expenditures 
for females are higher than for males for the ages 15 and 54. Above the age of 54 the 
expenditures for males are higher for males than for females.    
In Tables 4a and 4b we present the estimated hospital expenditures for survivors 
and decedents separately for males and females. The table is based on the regression 
results presented in Table 3a combined with demographic information from Statistics 
Norway.  
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Table 3a: Results from weighted regression analysis of hospital expenditures 
assuming serial correlation in error terms  
 
Dependent variable: Per capita expenditures 
 Females  Males 
 Age  Mortality rate by age 
 
Age  Mortality rate by age 
Coefficient 
Standard 
error Coefficient 
Standard 
error 
 
Coefficient 
Standard 
error  Coefficient 
Standard 
error 
            
 0 23527.2*** (88.36) 119988.2*** (11426.8)  25429.8*** (87.78)  65412.4*** (9828.8) 
1-4 1458.2*** (55.61) 215537.1*** (15404.9)  2255.0*** (55.06)  176742.4*** (15258.7) 
5-9 171.4*** (50.59) 193107.8*** (23562.0)  585.5*** (51.61)  96843.6*** (17469.4) 
10-14 Reference group 111588.5*** (22256.4)  112.9* (51.61)  129338.8*** (19598.0) 
15-19 966.9*** (51.40) 87140.5*** (15862.7)  611.1*** (52.49)  64229.1*** (9845.1) 
20-24 2671.1*** (53.31) 60250.2*** (13546.0)  1023.1*** (53.24)  43107.9*** (7481.1) 
25-29 4675.9*** (52.23) 68019.8*** (12891.9)  1113.7*** (52.33)  44369.7*** (7766.7) 
30-34 5121.4*** (51.13) 80850.6*** (12473.2)  1431.9*** (51.09)  53933.5*** (7922.2) 
35-39 4051.6*** (50.94) 103846.1*** (10135.8)  1860.0*** (50.86)  50064.8*** (7338.8) 
40-44 3368.7*** (51.68) 118871.9*** (8539.3)  2443.2*** (51.46)  89489.5*** (6177.9) 
45-49 3946.7*** (52.60) 132076.5*** (6305.6)  3441.8*** (52.60)  75365.7*** (4960.4) 
50-54 5039.8*** (53.55) 140986.2*** (4841.1)  4975.2*** (53.98)  95812.3*** (3984.0) 
55-59 6554.6*** (55.64) 138076.1*** (3977.4)  7250.8*** (56.34)  107490.7*** (3092.0) 
60-64 8669.5*** (59.28) 121013.7*** (3155.1)  10227.9*** (61.15)  105001.6*** (2366.4) 
65-69 11038.7*** (64.33) 109558.5*** (2532.2)  13890.7*** (68.90)  95870.9*** (1853.0) 
70-74 13846.3*** (69.05) 99365.6*** (2007.7)  17779.9*** (76.86)  81194.3*** (1448.1) 
75-79 17023.1*** (74.85) 61976.1*** (1457.7)  21308.7*** (86.99)  63649.4*** (1097.0) 
80-84 18933.6*** (86.07) 39107.5*** (1054.5)  22987.3*** (105.9)  46879.7*** (863.3) 
85-89 20119.3*** (108.9) 22423.0*** (793.4)  23969.9*** (140.8)  29566.5*** (713.3) 
90+ 19039.2*** (128.0) 5935.6*** (433.9)  22770.4*** (197.7)   15246.1*** (525.2) 
       
  Constant   -363.4***  (41.49)     
  Year     
   1998 Reference group     
    1999 542.0*** (24.59)     
    2000 349.6*** (27.28)     
    2001 945.7*** (27.86)     
    2002 1413.9*** (27.96)     
    2003 1869.4*** (27.96)     
    2004 1844.2*** (27.93)     
    2005 2184.7*** (27.89)     
    2006 2489.5*** (27.82)     
    2007 2733.4*** (27.77)     
    2008 2463.6*** (27.66)     
    2009 2744.9*** (27.68)     
 
Note: * for p<0.05, ** for p<0.01, and *** for p<0.001. Number of observations: 991 930.  
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Table 3b: Results from weighted regression analysis of hospital expenditures 
assuming serial correlation in error terms – without controlling for mortality  
 
Dependent variable: Per capita expenditures 
 Females 
 
Males 
Coefficient 
Standard 
error 
 
Coefficient 
Standard 
error 
      
 0 23796.5*** (84.27)  25596.7*** (82.60) 
1-4 1503.5*** (56.64)  2297.7*** (56.02) 
5-9 179.8*** (51.56)  586.0*** (52.70) 
10-14 Reference group   116.8* (52.70) 
15-19 976.2*** (52.31)  629.9*** (53.39) 
20-24 2673.8*** (54.29)  1045.8*** (53.90) 
25-29 4679.2*** (53.15)  1140.0*** (52.87) 
30-34 5133.9*** (51.95)  1468.0*** (51.56) 
35-39 4103.1*** (51.66)  1906.7*** (51.15) 
40-44 3475.1*** (52.12)  2575.8*** (51.58) 
45-49 4148.6*** (52.75)  3619.0*** (52.26) 
50-54 5399.6*** (53.14)  5351.6*** (52.65) 
55-59 7103.2*** (54.42)  7925.2*** (54.01) 
60-64 9425.0*** (57.06)  11330.6*** (57.11) 
65-69 12111.3*** (60.66)  15590.3*** (61.89) 
70-74 15465.2*** (62.10)  20182.8*** (65.18) 
75-79 18854.4*** (62.43)  24524.3*** (68.36) 
80-84 21043.6*** (65.33)  26977.9*** (77.06) 
85-89 22333.2*** (75.23)  28074.7*** (100.3) 
90+ 20166.3*** (96.77)  26409.1*** (154.9) 
     
        Constant  -290.1***    (42.33)  
 Year  
 1998 Reference group 
 1999 545.1*** (24.90)  
 2000 335.5*** (27.72)  
 2001 923.0*** (28.34)  
 2002 1388.9*** (28.47)  
 2003 1819.3*** (28.46)  
 2004 1775.5*** (28.43)  
 2005 2104.8*** (28.39)  
 2006 2397.9*** (28.33)  
 2007 2640.3*** (28.27)  
 2008 2361.0*** (28.16)  
 2009 2628.1*** (28.18)  
     
Note: * for p<0.05, ** for p<0.01, and *** for p<0.001.  
Number of observations: 991 930.  
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Figure 2: Estimated increase in per capita hospital expenditures associated with the 
last year of life at different ages 
 
 
 
Figure 3: Estimated per capita hospital expenditures by age excluding the effect of   
mortalities 
 
As expected, the decedents have a higher per capita expenditure than survivors for all age 
groups. The number of decedents is small compared to the number of survivors, and the 
total expenditures are therefore higher for survivors than decedents. This holds for all age 
groups. In Tables 4a and b we see that even though the estimated MRE is falling with age, 
the total share of the hospital expenditures used by decedents increases with age. This is 
caused by the higher number of decedents in higher age groups. We also see that 10% of 
the total hospital expenditures for males are used by male decedents, whereas the 
corresponding figure for females is 8%. In total, for both genders, hospital expenditures 
among decedents comprise 9.0% of total hospital expenditures. In the international 
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literature (Scitovsky, 1984; Polder et al., 2006; Hogan et al., 2001; Nord et al., 1989; 
Emanuel, 1996) the health care expenditures associated with the last year of life are 
estimated to be somewhere in between 10% and 30% of the total health care expenditures. 
The different studies include different components of total health expenditures, and/or 
selected segments of the population; hence, the results from different studies are not 
directly comparable.  
In Tables 4a and b the demographic composition are the average over the period of 
observations (1998-2009). In the following sections, we will change this composition in 
order to observe how this may change the expenditure patterns. First, we hold the 
demographic composition equal to the one observed in 1998 and then 2009. Based on the 
composition in 1998, the share of total health care expenditures used by decedents is equal 
9.8%. Based on the demographic composition in 2009, the corresponding number is 8.1% 
(see Table 5). The reason for the decline is two-fold. First, increased length of life 
increases the number of mortalities in higher ages with lower mortality related 
expenditures. Second, the share of decedents decreases in the time period. 
Table 4a: Estimated expenditures in 1000 NOK for males per year 
Age 
MRE 
per 
capita 
No. of 
Decedents 
Expenditure 
per capita 
excluding 
MRE 
No. of 
Survivors 
Total 
expenditure 
for 
decedents 
Total 
expenditure 
for 
survivors Total*  
Share 
used by 
decedents 
0 65 100 27 29606 9191 791072 800263 1 % 
1 - 4 177 41 4 119896 7445 425048 432492 2 % 
5 - 9 97 20 2 154720 1943 290200 292143 1 % 
10 - 14 129 18 1 155041 2383 217522 219906 1 % 
15 - 19 64 76 2 146764 5016 279031 284047 2 % 
20 - 24 43 136 2 140607 6185 325262 331447 2 % 
25 - 29 44 156 2 151930 7279 365213 372492 2 % 
30 - 34 54 172 3 169348 9720 460968 470688 2 % 
35 - 39 50 216 3 175738 11505 553592 565097 2 % 
40 - 44 89 273 4 169022 25481 631021 656502 4 % 
45 - 49 75 397 5 159694 31829 755667 787496 4 % 
50 - 54 96 626 6 154606 63855 968651 1032505 6 % 
55 - 59 107 887 9 140076 102943 1196386 1299329 8 % 
60 - 64 105 1192 12 113146 138882 1303220 1442103 10 % 
65 - 69 96 1529 15 85009 169782 1290503 1460285 12 % 
70 - 74 81 2171 19 71603 217638 1365470 1583108 14 % 
75 - 79 64 3243 23 61155 279690 1382030 1661720 17 % 
80 - 84 47 3990 24 42454 283901 1030663 1314565 22 % 
85 - 89 30 3397 25 20720 186226 523382 709608 26 % 
90 + 15 2235 24 7244 87853 174284 262137 34 % 
Total 
all age 
groups         
1648747 14329185 15977933 10 % 
         
*Total expenditures = Total expenditures for survivors + Total expenditures for decedents =[(Constant term 
weighted by the number of observations each year+ marginal increase in health care expenditures excluding 
MRE)* # survivors] + [Constant term weighted by the number of observations each year + marginal increase 
in health care expenditure excluding MRE + MRE)* # decedents].   
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Table 4b: Estimated expenditures in 1000 NOK for females per year 
Age 
MRE 
per 
capita 
No. of 
Decedents 
Expenditure 
per capita 
excluding 
MRE 
No. of 
Survivors 
Total 
expenditure 
for 
decedents 
Total 
expenditure 
for 
survivors Total* 
Share 
used by 
decedents 
0 120 74 25 28124 10698 697961 708658 2 % 
1 - 4 216 32 3 114266 7092 314041 321134 2 % 
5 - 9 193 15 1 147036 3012 214900 217912 1 % 
10 - 14 112 16 1 146941 1772 189574 191346 1 % 
15 - 19 87 34 2 139204 3073 314194 317267 1 % 
20 - 24 60 44 4 135637 2801 537286 540088 1 % 
25 - 29 68 57 6 148745 4181 887420 891601 0 % 
30 - 34 81 72 6 164195 6279 1052742 1059020 1 % 
35 - 39 104 106 5 168451 11563 899825 911387 1 % 
40 - 44 119 158 5 161787 19546 753742 773288 3 % 
45 - 49 132 247 5 153788 33960 805356 839317 4 % 
50 - 54 141 393 6 149090 57894 943724 1001618 6 % 
55 - 59 138 555 8 136208 80966 1068518 1149484 7 % 
60 - 64 121 723 10 113929 94740 1134689 1229429 8 % 
65 - 69 110 902 12 91409 109911 1126963 1236874 9 % 
70 - 74 99 1398 15 84252 160062 1275279 1435340 11 % 
75 - 79 62 2490 18 82019 199913 1502025 1701938 12 % 
80 - 84 39 4018 20 69732 238396 1410252 1648648 14 % 
85 - 89 22 4987 21 44446 218587 951558 1170145 19 % 
90 + 6 5470 20 22153 143658 450348 594007 24 % 
Total 
all age 
groups 
1408104 16530397 17938501 8 % 
         
*Total expenditures = Total expenditures for survivors + Total expenditures for decedents =[(Constant term 
weighted by the number of observations each year+ marginal increase in health care expenditures excluding 
MRE)* # survivors] + [Constant term weighted by the number of observations each year + marginal increase 
in health care expenditure excluding MRE + MRE)* # decedents].  
 
In order to further investigate the influence of changes in demographic composition on 
health care expenditures we hold the number of inhabitants equal to that in 2009, but hold 
the mortality rates equal to 1998. By this approach the share used by decedents increase to 
10.0 % in 2009 (see Table 5).  The reason for the increase is increased mortality rates for 
almost all age groups apart from the 90+ age group. Hence, an increased length of life 
reduces the mortality related hospital expenditures. Furthermore, the increased length of 
life leads to a reduction in the total expenditures with 2% (0.6 billion NOK) (see Table 5). 
In summary, our results supports the claim that mortalities are, ceteris paribus, 
associated with higher hospital expenditures. We show that when life expectancy 
increases the naïve models will produce biased projections of future hospital expenditures. 
The results also show that even though the decedents incur high expenditures on hospital 
services, the decedent’s expenditures comprise a relatively small share of the total hospital 
expenditures (9 %). 
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Table 5: The effect of increasing longevity on total hospital expenditures in Norway 
- Assuming the same per capita expenditures as in the regression presented in Table 3, but 
changed demographic composition5 
 
  
Demographic composition as in 
2009 
Demographic composition as in 
1998 
Demographic composition as in 
2009, but mortality rates as in 
1998 
Male Female Males Female Males Female 
Age # D # S # D # S # D # S # D # S # D # S # D # S 
0 96 31737 58 29916 129 29497 85 28192 139 31694 90 29884 
1-4 33 122577 30 116642 49 123554 43 116730 49 122561 43 116629 
5-9 17 151276 13 145132 22 155843 11 147574 21 151272 11 145134 
10-14 14 160836 13 152417 21 138363 19 131782 24 160826 22 152408 
15 - 19 73 163948 37 155177 70 133768 35 127232 86 163935 43 155171 
20 - 24 105 153315 46 146643 164 141842 44 137927 177 153243 47 146642 
25 - 29 145 151494 52 146855 177 169082 58 164089 159 151480 52 146855 
30 - 34 139 159013 59 153778 202 175598 92 166903 183 158969 85 153752 
35 - 39 185 181973 98 173849 250 163026 114 155779 279 181879 127 173820 
40 - 44 274 186904 133 176770 325 158962 183 153781 382 186796 210 176693 
45 - 49 341 171124 230 162081 436 152679 253 145844 488 170977 281 162030 
50 - 54 576 161823 398 155927 729 154386 474 147707 763 161636 500 155825 
55 - 59 869 149491 494 145311 783 107923 462 107431 1083 149277 624 145181 
60 - 64 1370 146777 843 144273 1163 85527 592 89905 1987 146160 949 144167 
65 - 69 1576 104472 976 107548 1701 81305 924 89531 2173 103875 1109 107415 
70 - 74 1846 73750 1250 83800 2788 75778 1676 92348 2683 72913 1516 83534 
75 - 79 2608 58670 1916 74087 4019 64204 3116 91629 3610 57668 2500 73503 
80 - 84 3524 43704 3469 65401 4079 38114 4246 67322 4566 42662 4086 64784 
85 - 89 3695 25000 5220 50212 3081 17652 4793 39129 4264 24431 6049 49383 
90 + 2609 8907 6238 26781 1446 5906 4262 18078 2265 9251 6299 26720 
Expenditures 
Share of total health care 
expenditures used on decedents 
8.1% 
 
Total expenditures in billion  
NOK 35.8 
Share of total health care 
expenditures used on decedents 
9.8% 
 
Total expenditures in billion  
NOK 32.8 
Share of total health care  
expenditures used on decedents  
10.0% 
 
Total expenditures in billion  
NOK 36.4 
 
5 Policy implications and conclusion  
In our analysis we find that 9% of all hospital expenditures from 1998 to 2009 were spent 
on individuals in their last calendar year of life. Our analysis also suggests that mortality 
related expenditures are a decreasing function of age.  
Our analysis supports the inclusion of both mortalities and age in predictions of 
future hospital expenditures. We provide an estimate of how increasing longevity over a 
twelve year period has influenced total hospital expenditures in Norway, and find that it 
had an impact of 2 percentage points in the period 1998-2009. Thus we conclude that the 
naïve approach is insufficient to predict future health care expenditures.  
                                                
5  #D : Number of decedents       ,          #S : Number of survivors 
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The Red Herring Hypothesis as it was formulated by Zweifel et al. (1999) states that; 1) 
time to death do influence health care expenditures, 2) age do not influence health care 
expenditures. We use the mortality rate in the last calendar year of life, and not time to 
death. Hence, our assumptions and empirical specification is not tailored to test the Red 
Herring Hypothesis. Given the assumption that our regression equation is correctly 
specified, we clearly reject the hypothesis that hospital expenditures is unaffected by age. 
The main implication of our results is that increasing longevity may bring about 
reductions in mortality related expenditures as death is postponed until higher ages, and 
these reductions in mortality related health expenditures should be taken into account 
when predicting future health expenditures. Furthermore, as mortality related expenditures 
are dependent on age, our study suggest that only including time to death without the 
interaction with age, will give misleading results when predicting future health care 
expenditures. 
Finally, it is important to emphasize that several other factors such as technological 
progress and general growth in gross domestic product influence the health care spending, 
and not demographic factors alone (Häkkinen et al., 2008). 
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Abstract Some researchers claim that health care
expenditures for older people are growing faster than for
the rest of the population. This process is referred to as
steepening. The aim of this paper is to test steepening,
applying new data and revised methods. Furthermore, we
explain the connection between the terms red herring
hypothesis, i.e., that time to death and not age per se drives
the health care expenditures, and steepening. We also
present the mechanisms that may induce steepening, as
presented in the literature. When testing steepening, we
apply data from all inpatient stays in somatic hospitals in
Norway in the period 1998–2009, i.e., the data has no self-
selection and covers the entire population of Norway (5
million). Our analysis does not reject steepening, with the
exception of the 0-year-olds. The results also hold when
controlling for mortality-related expenditures. Further-
more, we observe an increase in expenditures for the
0-year-olds. Finally, we ﬁnd increasing mortality-related
expenditures over time. We ﬁnd the link between steep-
ening and the red herring hypothesis to be vague, and we
ﬁnd steepening and the red herring hypothesis to be
independent.
Keywords Red herring hypothesis  Hospital
expenditure  Trends in health care expenditures 
Steepening  Ageing
JEL Classiﬁcations A19  I15  I19
Introduction
The proportion of the elderly population in the countries of
the Organization for Economic Co-operation and Develop-
ment (OECD) will increase substantially in the coming
years. Knowledge regarding the distribution of per capita
health care costs between different age groups is essential in
order to forecast future health care expenditures. In this
study, we discuss the long-term development of health care
expenditures. Even though the long-term developments for
the entire population are discussed in detail in several papers
[1, 2], the speciﬁc increase for different age groups is poorly
covered. This is vital in order to understand the long-term
developments in health care expenditures. In this paper, we
will investigate the speciﬁc growth for different age groups.
When discussing trends in health care expenditures,
two concepts are often brought up in the literature: red
herring hypothesis and steepening. The red herring
hypothesis states that health care expenditures are driven
by time to death, not age per se [3]. Steepening states
that the growth in per capita health care expenditures for
older people is higher than for the rest of the population
[4]. In this paper, we will focus on the latter, but clarify
the relation between the terms. The aim of the clariﬁ-
cation is threefold. First, in the literature [4, 5], the
connection between steepening and the red herring is
vaguely described, so a clariﬁcation will therefore con-
tribute to the steepening literature. Second, a discussion
of the link between the terms will contribute to further
understanding of the concept of steepening. Third, sev-
eral methodological issues discussed in the red herring
debate also apply in the steepening debate, and hence
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bringing in the red herring literature will improve the
steepening debate.
The aim of this paper is threefold. First, we measure
changes in health care expenditures over time, in order to
test if steepening may be rejected. Second, we present
mechanisms that may induce steepening, as presented in
the literature. Third, we attempt explain the connection
between red herring and steepening.
When testing steepening, we apply a complete data set for
inpatient hospital expenditures in Norway from 1998 to
2009. We use diagnostic related groups (DRG) weights to
measure the hospital expenditures. Norway has a National
Health Service similar to the one we ﬁnd in other Scandi-
navian countries and the United Kingdom (UK). The hos-
pitals are public and ﬁnanced through general taxation [6].
The contribution of this paper is that we elaborate on the
link between red herring and steepening more than has
previously been done in the literature [4, 5]. We also
summarize the literature on mechanisms that may induce
steepening. Furthermore, the estimation techniques previ-
ously presented in the literature are improved and the
previous methods are replicated. The data set applied to
test steepening is of high quality, with no self-selection
over a long period of time.
The paper proceeds as follows: ﬁrst, we present the
terms steepening and red herring with the present litera-
ture, and discuss in detail what may induce steepening.
Secondly, we explain the link between the two concepts.
Thirdly, we test steepening. In the third part, we ﬁrst
present the data, then the methods and the results. Fourth,
we present the conclusion and discussion.
Background
‘‘If steepening [occurs]…, the future increase of health care
costs will even be larger than in the predictions which keep
expenditure proﬁles constant’’[4] p 582.
From the quote above, steepening may be seen as a
contradiction to the more optimistic future scenarios
described in the red herring debate [2], which claim that
future health care expenditures will be lower than previ-
ously expected, due to an increased length of life. How-
ever, as we will return to in the end of this section, both
hypotheses may in fact hold at the same time. Before the
link between the terms is explained in more detail, we will
summarize the literature on the steepening and brieﬂy
mention the red herring literature.
Steepening
In 2006, a new term regarding health care expenditures and
older people was introduced by Buchner and Wasem [4]
that suggested per capita health care expenditures would
grow faster for the elderly than for younger people, i.e., a
situation characterized by steepening. Steepening was
deﬁned as the increase in the ratio of per capita expendi-
tures for older people (65?) divided by the younger (below
65), over time:
Ya2½65;106;t=Ya2½0;64;t[ Ya2½65;106;t1=Ya2½0;64;t1 ð1Þ
where Ya2½65;106;t is the per capita expenditures for the
elderly (aged above 65?) in year t.
Note that in their regression analysis they deﬁned the
young to be between 30 and 64, while the old were
between 65 and 79 [4]. To make the age limits more
comparable with the other deﬁnition (2) of steepening
presented in this paper, we will use the age limits as pre-
sented in deﬁnition (1) throughout this paper. Also note
that Buchner and Wasem [4] include other deﬁnitions of
steepening that we will return to in the ‘‘Methods’’ section.
Based on the same deﬁnition, but without using the term
steepening, health data from OECD between 1984 and
1998 indicates steepening in several countries, among them
the United States (US), Finland and Japan. However, this
pattern is not found in the UK [7], where a decline in the
expenditures for the elderly compared to the rest of the
population is observed. There are also other studies that
suggest health care expenditures grow faster for the elderly
than the rest of the population [8–11]. There are, however,
methodological issues connected to the simple method
(deﬁnition) used in these papers, which we will discuss in
more detail later. Some of the methodological issues are
solved by Felder and Werblow [5], who deﬁned steepening
as a positive cross derivative of per capita health care
expenditures with respect to age and time:
o2Ygða; tÞ
oaot
[ 0: ð2Þ
Note that Felder and Werblow [5] included mortality rates
in the function of per capita expenditures, in contradiction
with the deﬁnition by Bucher and Wasem [4], as they
deﬁned steepening in three dimensions (age, per capita
expenditures and time). Therefore, in the rest of this section
we will ignore the impact of mortalities.
Deﬁnition (2) forms the basis of this paper, but results
based on both deﬁnitions (1) and (2) will be presented later.
The reason for focusing on the latter deﬁnition is that the
deﬁnition is more ﬂexible with respect to model speciﬁ-
cation, and in our view it captures the concept as it was
originally formulated by Bucher and Wasem [4]. A wider
discussion on the different deﬁnitions of steepening will be
presented in the methods section.
Felder and Werblow [5] mention several factors that
may lead to steepening or reduce the effect of steepening.
We will give a short summary in the following section.
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They suggest that steepening may arise due to increased
‘‘maintenance’’ costs as length of life increases, or simply
as a bias in the technological frontier (more innovations in
medical treatments for older people). They also mentioned
that, to the contrary, per capita mortality-related expendi-
tures for hospitals are decreasing with age; hence,
increased length of life might reduce mortality-related
expenditures. This is supported in several studies [12–14].
Felder and Werblow [5] also suggest that, due to com-
pression of morbidity, the period of illness will be com-
pressed over time, which will in turn reduce the per capita
health care expenditures related to older people [15].
Another paper discussing the reasons for growth in health
care expenditures for the elderly is written by Barer et al.
[11]. They discuss the implications of changes in morbidity
and mortality and how that might change utilization for
health care. Their study is formed around rectangularization
of survival curves over time, compression of mortality [16],
and compression ofmorbidity [15]. They argue that based on
the preferences of society to either accept ‘‘natural death’’ or
use all resources possible to reduce morbidity, the com-
pression ofmortality andmorbiditywill inﬂuence health care
expenditures in different ways. If society accepted ‘‘natural
death’’, health care expenditures for the elderly will drop
over time, while if society minimizes morbidity it will
increase expenditures for elderly.
In summary, the literature on the causes of increased
expenditures for the elderly indicates that there might be a
technological bias and changes in biological factors (mor-
bidity). With regard to the ﬁrst, the technological bias is
likely to be driven by some underlying mechanisms that are
poorly explained by Felder and Werblow [5]. One reason
might be biological changes over time, but there could also
be other mechanisms driving steepening.
Red herring
The red herring hypothesis was formulated by Zweifel
et al. [3], and states that health care expenditures are driven
by time to death and not age per se. A similar idea had
previously been presented by Fuchs [17]. Zweifel et al. [3]
formulated precisely as:
The health care expenditures for an individual (i) inde-
pendent of age:
oYiða; kÞ
oa
¼ 0 ð3Þ
where a is age and k is quarters to death.
The health care expenditures are dependent on quarters
to death:
oYiða; kÞ
ok
6¼ 0: ð4Þ
Several studies have tested the red herring hypothesis
(see, among others, [2, 18, 19]); i.e., the studies have tested
how time to death and age for a sample of the population
may explain the observed health care expenditures. Some
of the studies reject, while other support, the red herring
hypothesis.
In the red herring debate, several methodological
problems have been raised (see. among others. [20, 21]).
The debate is summarized in Ha¨kkinen et al. [22] by
pointing at two econometrical issues: ﬁrst, multicollinearity
between the explanatory variables (age and time to death),
and second, endogeneity between health care expenditure
and time to death (mortalities). Both these issues will be
relevant in the ‘‘Methods’’ section in Eqs. 10, 11, 14 and
16. Gregersen and Godager [13] apply the same data set as
we do in this study, and discuss both these issues in detail.
In summary, ﬁrst, the multicollinearity is of minor impor-
tance, as the data set is large; second, the assumption that
mortalities are exogenous is not rejected.
The link between steepening and red herring
By deﬁnition, steepening is deﬁned in three dimensions
(age, time, and per capita health care expenditures) as is the
red herring (age, time to death and individual health care
expenditures). As the dimensions in the terms differ with
respect to time and time to death, the link between the
terms is not obvious, and both hypotheses may hold at
once. Furthermore, when comparing (2) (steepening) with
(3) and (4) (red herring), the deﬁnitions of the terms do not
contradict or support each other. In summary, we therefore
conclude that the terms are independent.
Data
For this study, we have repeated cross-sectional data
(pseudo-panel) for all hospital admissions in Norway from
1998 until 2009. The data comes from theNorwegian Patient
Registry (NPR). The data was merged with demographic
characteristics from Statistics Norway (SSB). The data from
NPR provides a complete registry of all hospital admissions
in Norway from January 1998 to December 2009. The
dataset contains data on somatic in patient care. Registration
in NPR is compulsory for all hospitals, and therefore there is
no self-selection in the dataset. Each admission to the hos-
pital (hospital stay) is registered as an observation, and it is
not possible to track individuals between admissions. The
dataset contains ﬁve variables; year of birth, gender, year of
hospital stay, DRG-points (diagnostic related group) and
place of residence of the patient (municipality). Data on the
number of inhabitants (N) are given by SSB (Table 1).
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In order to get per capita measures, we aggregated the
data by grouping the data so the smallest possible cell is
deﬁned by a given age (ai), gender (qi), year (ti) and
municipality (mi). The 430 municipalities, 106 ages, 2
genders and years of observation (1998–2009) gave
1,093,920 unique cells that form the dataset our analysis is
based on. We index the cells with the index g (g = 1,
2…,1,093,920).
The per capita expenditure in one cell is:
Yg ¼ 1
Ng
X
i2g
Yi ð5Þ
The per capita hospital expenditures in year (t) are
deﬁned by:
Yt ¼ 1
Nt
X
i2t
Yi ð6Þ
For the rest of this paper, the expenditure will be
measured in Norwegian kroner (NOK), inﬂation adjusted
to 2010 NOK {8 NOK = 1 € [Norwegian Bank (2010)]}.
In Fig. 1 we present per capita expenditures as a function
of age. To explore how expenditures have developed over
time for different age groups, we compared the per capita
expenditures for the ﬁrst 6 years with the last 6 years in the
dataset. We aggregate the total health care expenditures for
each age (a) and divide by the number of inhabitants with
age (a), for each of the two time periods (1998–2003 and
2004–2009). If we denote the start of a period by t1 and the
end by t2 (for example t1 = 1998 and t2 = 2003) the health
care expenditures for age (a) in Fig. 1 is deﬁned by:
Y
a;t2 t1;t2½  ¼
1
Na;t2 t1;t2½ 
X
i2 a;t2 t1;t2½ f g
Yi: ð7Þ
The ﬁgure clearly shows that the per capita health care
expenditures for the older people and newborns (0 years
of age) have increased substantially over time during the
period of observation. Except for newborns, the expen-
ditures for older people increased more than for the rest
of the population. If newborns are excluded, the ﬁgure
shows that the expenditures for older people have grown
faster than for the rest of the population, consistent with
steepening.
One reason for the increase in expenditures for new-
borns may be increased expenditures for premature infants.
Both Bratlid and Nordermoen [23] and Nordermoen and
Bratlid [24] discusses the increases in treatment expendi-
tures for treatment of premature infants in Norway. In
summary, they highlight that more premature infants with
low birth weight are treated, and advances in technology
not only increase the cost of treatment, but also improve
the quality of the treatment.
Table 2 compares demographic characteristics for the
ﬁrst 6 years (1998–2003) in the data set with the last
6 years (2004–2009). Comparing the two periods, the
average annual number of inhabitants has increased from
4.5 million in the ﬁrst period to 4.7 million in the last
period. The total number of decedents does decline over
time, comparing the same two periods from 263,627 to
249,902. The mortality rate (number of decedents divided
by the total population) for most age groups is falling over
time, apart from the age groups containing the individuals
aged between 5 and 14.
Methods; identifying steeping
In Buchner and Wasem [4], three methods are presented
with which to identify steepening. The ﬁrst is based on
deﬁnition (1); using this approach, they ﬁnd clear evidence
of steepening. As they state, the clear advantage of this
simple method is that it is transparent and easy to replicate.
On the other hand it does not investigate changes within the
two age groups—the younger and older people. This is
closely related to:
Ya2½65;106;t=Ya2½0;64;t ¼ w0 þ w1  t: ð8Þ
Second, they suggest a slightly modiﬁed method, using a
benchmark age group, and compare the growth of the other
age groups relative to the benchmark age group:
Ya;t
Ybenchmark;t
¼ k0;a þ k1;a  t: ð9Þ
Finally, they suggested a model with health care
expenditures as an exponential function of age. Buchner
and Wasem [4] only had 20 age groups and two genders,
each year for 18 years (20 9 18 9 2 = 720 observations).
The data limitations put strong limitations on their
regression methods. The methods were later signiﬁcantly
improved by Felder and Werblow [5]. They had more
variation in the data (a larger data set) with 26 regions, both
genders, 10 years and 20 age groups, i.e., 10,400
observations. This allowed for a more complex model.
They assumed that the health care expenditures are a
function of time (t) and demographics [age (a), gender (q)
and mortality rate ð/Þ]:
Per capita health care expenditure
¼ Constantþ b  genderþ c  ageþ h  time
þ j mortality rateþ l  age  timeþ error term $
ð10Þ
Yg ¼ a þ b  q þ c  aþ h  t þ j  /g þ l  a  t þ eg:
ð11Þ
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In Eqs. 10 and 11,1 b indicates the marginal increase in
cost for females compared to males, and h captures yearly
growth in per capita expenditures, while l measures the
age speciﬁc growth rate as deviation from the yearly
growth rate (h), j is the increase in per capita hospital
expenditures due to mortality rate, and c is the impact of
age on per capita expenditures. Finally, e is the error term.
In this setting, steepening was deﬁned by (2).
Note that Felder and Werblow [5] argue that hospital
expenditures grow exponentially over time. To test if an
exponential or linear model applies to our data set, we ran
two regressions: ﬁrst, keeping the dependent variable as a
linear function of time, and second, keeping the dependent
variable as an exponential function of time:
Yg ¼ h0 þ h1  t ð12Þ
with R2 = 0.0095 and ln Yg ¼ h0 þ h1  t with
R2 = 0.0019.
From Eq. 12 we see that the R2 is low in both the
exponential and linear model, but slightly higher in the
linear model. Based on the result, the difference between
the two models is small and both models may apply.
However, we choose to apply a linear model due to the
slightly higher R2.
Felder and Werblow [5], argue that o
2Y
oaot is a function not
only of la, but also of the mortality rate /. They assume
that o
2/
oaot\0 due to increased length of life. Therefore, we
tested the magnitude of changes in mortality rate from
changes in age and time:
/g ¼ a0 þ a1  t  aþ a2  aþ a3  t þ eg: ð13Þ
In the rest of the methods section, we will ignore the
impact of changes in mortalities on steepening, but we will
come back to this issue in the results section.
Further, as stated earlier, Felder and Werblow [5] only
had 20 age groups (dz) in their data set, limiting their
analysis to 14. As we have more variation in the age var-
iable, we are not forced to keep the same grouping of the
regression parameter. However, per capita expenditure is
not a linear function of age (see Fig. 1); therefore, we also
treat age as a categorical variable, with 21 groups,
respectively. The reasons for keeping age to 21 groups only
are twofold. First, it will make the results easier to compare
to the methods presented by Felder and Werblow [5].
Second, if age is treated with one-year age-groups, the
number of observations in each group declines, and
therefore the precision of each estimate will drop. In
summary, as the estimate of interest here is the differences
in growth between the young and old, and not the speciﬁc
growth rate for each age per se, we therefore ﬁnd the
grouping similar to the one found in Felder and Werblow
[5] to be sensible in this analysis:
Yg ¼ aþ b  qþ
X20
z¼0
cz  dz þ h  t þ
X4
x¼1
jx  ð/gÞx
þ
X20
z¼11
lzdz  t þ eg ð14Þ
dz is a dummy for indicating age group (0, 1–4, 5–9,
…, 90?), em;a;t;q represents the error term, and lz
measures the deviation in growth rate for age group z
compared to the young [below 50 (z\ 11)]. As lz2f1;10g
is the benchmark age group, steepening is for age group
z as deﬁned by:
lz  lz2f1;10g[ 0 for z[ 10, indicating that the growth
rate for the elderly is higher than for the young.
Steepening within the 50? age group is deﬁned by
lzþ1  lz[ 0 for z[ 10.
The reasoning for choosing the speciﬁc functional
form to capture the mortality-related expenditures in
Table 1 Descriptive statistics: expenditures
Variable Number of observations Mean Std. dev. Min Max
Per capita expenditures by year: Yt ¼ 1Nt
P
i2t
Yi 12 7,340.71 947.5119 5,786.21 8,595.46
Per capita expenditures by group: Yg ¼ 1Ng
P
i2g
Yi 995,158 10,453.61 17,145.92 0 1,006,657
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Fig. 1 Hospital expenditures per capita measured in NOK over age
1 Note that g denotes a cell in the data set applied in this study,
characterized by age, gender, time and municipality.
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Eq. 14 is poorly described by Felder and Werblow [5].
From several papers [12–14], it is known that mortality-
related health care expenditures are a decreasing function
of age. We therefore include the interaction between age
and mortalities ðage  /Þ in our analysis. Furthermore,
we cannot ﬁnd any studies supporting the inclusion of
mortalities to the power of two, three and four (x = 2, 3,
4). We therefore choose to only include mortality rate to
the power of one (x = 1). The number of mortalities,
due to compression of morbidity, increases for the
highest age groups (see Table 2). We would therefore
expect, as mortality related expenditures decrease with
age, to observe a reduction in the mortality related
expenditures over time. To capture the latter effect, we
include the interaction between mortalities and time,
which we expect to be negative:
o2Yg
o/ot
¼ k\0: ð15Þ
Finally, we also include the yearly growth rate for all
age groups (lz, z = 0, 1, ..., 20), to identify differences
within the young. We are now left with the equation that
forms the basis of our analysis:
Yg ¼ aþ b  qþ
X20
z¼0
cz  dz þ h  t þ j  /g þ g  /g  a
þ
X20
z¼0
lz  dz  t þ k  /g  t þ eg ð16Þ
We note that the error terms in Eqs. 10–16 are
heteroscedastic, due to variation in the size of the cells,
Ng. We therefore weight the regressions by the number of
inhabitants in each cell.
Results
This section will present estimations based on the methods
presented in methods section. The share of the per capita
health care expenditures used by the elderly (65?) does not
increase over time (1998–2009) (Table 3). This holds even
though we exclude the newborns. On the contrary, the
share used by the younger group is highest in 1998. The
estimation based on Eq. 1, therefore, does not support
steepening. When running a regression on Table 3,
equivalent to (8), we ﬁnd a negative and signiﬁcant effect
Table 2 Descriptive statistics: demographic characteristics
Age 2004–2009 1998–2003 Mortality rate
1–mortality rate 2
#Decedents Inhabitants Mortality rate 1 #Decedents Inhabitants Mortality rate 2
0 943 351,791 0.002681 1,146 342,773 0.003343 -0.0007
1–4 359 1,390,934 0.000258 531 1,420,461 0.000374 -0.0001
5–9 192 1,795,174 0.000107 231 1,827,422 0.000126 0.0000
10–14 186 1,868,604 0.0001 222 1,752,313 0.000127 0.0000
15–19 607 1,834,645 0.000331 718 1,591,994 0.000451 -0.0001
20–24 995 1,681,558 0.000592 1,168 1,634,271 0.000715 -0.0001
25–29 1,173 1,728,377 0.000679 1,378 1,886,462 0.00073 -0.0001
30–34 1,252 1,932,635 0.000648 1,681 2,077,068 0.000809 -0.0002
35–39 1,791 2,130,113 0.000841 2,084 2,000,640 0.001042 -0.0002
40–44 2,416 2,066,621 0.001169 2773 1,903,477 0.001457 -0.0003
45–49 3,699 1,931,564 0.001915 4,049 1,835,113 0.002206 -0.0003
50–54 5,741 1,847,509 0.003107 6,505 1,807,816 0.003598 -0.0005
55–59 8,617 1,776,023 0.004852 8,690 1,550,439 0.005605 -0.0008
60–64 12,527 1,586,827 0.007894 10395 1,148,655 0.00905 -0.0012
65–69 14,342 1,137,507 0.012608 14,833 1,004,696 0.014764 -0.0022
70–74 18,734 925,269 0.020247 24,233 989,335 0.024494 -0.0042
75–79 29,838 848,292 0.035174 39,216 941232 0.041,665 -0.0065
80–84 45,382 725,662 0.062539 50,893 716,681 0.071012 -0.0085
85–89 51,417 475,017 0.10824 49,216 405,885 0.12126 -0.0130
90? 49,691 244,942 0.20287 43,665 200,843 0.21741 -0.0145
Sum 249,902 28,279,064 263,627 27,037,576 -0.053386
Average sum by
year (sum/6)
41,650 4,713,177 43,938 4,506,263
F. A. Gregersen
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when including all ages w1 ¼ 0:021. Furthermore, when
excluding individuals\1 year of age, we ﬁnd a positive,
not signiﬁcant effect w1 ¼ 0:003. Overall, the estimation
effect based on (1) and (8) rejects steepening.
To identify steepening in Eqs. 10, 11, 14 and 16, the
magnitude of the changes in mortality over time has to be
identiﬁed. As discussed in the methods section, mortality
rates are decreasing over time, i.e., there is a compression
of mortalities (see Table 2). From the regression on (13),
we ﬁnd the effect to be small, signiﬁcant, and negative
(a1 ¼ 0:0000085) (see Table 4). To also estimate the
effect of changes in mortality rates over time in (14), i.e.,
mortality rate to the power of 1, 2, 3 and 4, we also
included regressions with the mortalities to the power of 2,
3, and 4 as the dependent variable in Table 4.
Table 5 presents four regressions. The ﬁrst is based on
Eq. 14 in the ‘‘Methods’’ section. As expected, the age
coefﬁcient for the younger age group is low (below 25),
apart from the 0-year-olds. The age coefﬁcient peaks for
the 70–75-year-olds. For the highest age groups, there is a
decline compared with the age group 70–75. We may not
reject steepening in this model based on the analysis:
o2Y
oaot
¼lþo
2P4
x¼1jx /ð Þx
oaot
¼ lzlz2 1;10f g
þo
2P4
x¼1jx /ð Þx
oaot
¼ lzlz2 1;10f g þ131415:8
 ð0:0000085Þþð446127:2Þ  ð0:00000147Þ
þ640520:0ð0:000000546Þþð310920:1Þ
 ð0:000000336Þ[0
:
ð17Þ
Within the group of older people (above 50), we ﬁnd
steepening for all age groups ðlzþ1  lz[ 0Þ apart from
Table 3 The share of total health care expenditures spent on the
elderly compared to the rest of the population
Year Including all ages
Ya2½65;106;t=Ya2½0;64;t
Excluding age zero
Ya2½65;106;t=Ya2½1;64;t
1998 4.524 4.760
1999 4.204 4.346
2000 4.290 4.442
2001 4.334 4.483
2002 4.117 4.452
2003 4.113 4.431
2004 4.143 4.496
2005 4.164 4.510
2006 4.098 4.447
2007 4.159 4.567
2008 4.107 4.490
2009 4.239 4.648
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the highest age group, above 90 ðl20  l19\0Þ. Further-
more, the effect of mortalities2
oYg
o/ [ 0
 
is positive, and
females have higher expenditures than males on average.
Second, the regression output based on Eq. 16 excludes
mortalities. In this regression, the 0-year-olds have the
highest yearly growth, of 2,700 NOK l0 ¼ 2700:4ð Þ. The
second-highest yearly growth is found for the 80–85-year-
olds, with 939.4. In comparison, the 5–9-year-olds have a
yearly growth rate of 38.12. The annual growth for young
individuals (i.e., below age 50) is lower than for those
individuals age 50 or greater, that is, apart from the new-
borns. This does not reject steepening if newborns are
excluded.
Third, the regression output based on Eq. 16 is pre-
sented, but now including the effect of mortalities, while
excluding the interaction between time and mortalities. As
expected, the effect of mortalities is positive, and as
expected the mortality related cost is a decreasing function
of age. Also, the age effect is slightly reduced here for each
age group, implying that part of the expenditures for each
age group is generated by mortalities. Especially for the
highest age groups, there is a decline from a model
excluding mortalities. The yearly growth rate for the dif-
ferent age groups are similar to the previous (second)
results presented, and the same interpretation regarding
steepening applies.
Finally, the results from running a regression on Eq. 16
both including the effect of the interaction of mortalities
and time are presented. When the interaction of time and
mortalities are included, the yearly growth rate is declining
for all age groups, apart from the 1–4 group. The yearly
growth for the 90? was 976.4; after the inclusion of the
interaction term it became 548.5, implying that part of the
growth for the highest age groups is caused by increased
mortality related costs over time ðk ¼ 2045:9Þ.
To summarize the results in Table 5, the ﬁrst regression
does not reject steepening (based on Eq. 14). In the fol-
lowing three regressions presented (based on Eq. 16), we
can also not reject steepening if excluding individuals
below age 1.
Conclusion and discussion
The ﬁrst part of this paper clariﬁed the connection between
steepening and the red herring hypothesis. We concluded
that the terms are independent. Furthermore, the data
applied in this study is insufﬁcient to test the red herring
hypothesis. The reason for the data ‘‘insufﬁciency’’ is that
the data do not contain information on time-to-death at the
individual level. Therefore, the data may not reject the
hypothesis as formulated by Zweifel et al. [3], i.e. (3) and
(4).
The ﬁrst part of this paper continued with summarizing
causes mentioned in the literature that may induce steep-
ening. In summary, the literature is limited and points at
biological and technological factors.
The second part of this paper was to test steepening.
Steepening was deﬁned by Buchner and Wasem [4] in three
dimensions: time, age and per capita health care expendi-
tures. In these dimensions, the term states that health care
expenditures should grow faster for older people than the
rest of the population. In these dimensions, we ﬁnd evi-
dence of steepening with the exception of the 0-year-olds,
i.e., Eq. 16, excluding mortalities. The method is similar to
the method found in Felder and Werblow [5]. When using
deﬁnitions (1) and (8), similar to the methods suggested by
Buchner and Wasem [4], we ﬁnd no evidence of steepen-
ing, including all ages. However, when excluding the
individuals aged zero, we ﬁnd a non-signiﬁcant effect in (8)
in favour of steepening. Our results are not directly com-
parable to Buchner and Wasem [4], as they only included
individuals between 30 and 70 years of age in their study.
Regardless of the age limits used, the latter model has little
ﬂexibility within the age groups (young and older), as there
is only one dummy for each group. From Fig. 1, it is clear
that per capita health care expenditures is not a linear
function of age, and a model allowing for more variation is
more appropriate. Overall, we therefore ﬁnd the results
based on Eq. 16, excluding mortalities, to be more reliable.
The second step in our empirical estimations was then to
estimate what factors may drive the steepening effect.
From several studies, among them Zweifel et al. [3] and
Seshamani and Gray [25], mortalities are an important
driver of health care expenditures. We would therefore
expect the effect of steepening to be reduced in Eq. 16,
including mortalities. In Table 5, it is shown that such a
decrease does not occur. However, when including the
interaction between mortalities and time, the steepening
effect strongly declines, i.e., part of the steepening effect is
driven by increased mortality-related expenditures over
time.
Several implications follow from the results. First, as
shown in several other studies (see, among others, [12, 26])
both mortality and age contribute to health care expendi-
tures. Second, per capita health care expenditures are
biased towards older individuals over time. Per capita
health care expenditures for infants are increasing more
than for the rest of the younger population. Third, if the
observed trend continues, expenditures for older individu-
als are likely to increase substantially in the future (both
2 oYg
o/g
¼ j1 þ 2j2/g þ 3j3/2g þ 4j4/3g ¼ 131416 2  446127  /g
þ3  640520  /2g  4  310920  /3g[ 08/g:
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Table 5 Results from regression analysis based on Eqs. 14 and 16
Dependent variable per capita expenditures ðYgÞ
Equation (14) (16) Excluding
mortalities
(16) Excluding the
interaction between time
and mortalities
(16) Including the
interaction between time
and mortalities
Independent variable Coefﬁcient Standard
er.
Coefﬁcient Standard
er.
Coefﬁcient Standard
er.
Coefﬁcient Standard
er.
Year (t) t = 0 if
year = 1998 t = 1 if
year = 1999 … t = 11 if
year = 2009 ðhÞ
142.1*** (2.024)
t 9 age ðlÞ
t 9 age 0 2,700.4*** (14.75) 2,731.0*** (14.39) 2,725.1*** (14.38)
t 9 age 1–4 76.86*** (7.365) 82.03*** (7.184) 81.43*** (7.181)
t 9 age 5–9 38.12*** (6.545) 38.74*** (6.384) 38.52*** (6.381)
t 9 age 10–14 44.18*** (6.598) 45.24*** (6.436) 45.02*** (6.433)
t 9 age 15–19 58.88*** (6.699) 62.99*** (6.534) 62.24*** (6.531)
t 9 age 20–24 53.80*** (6.751) 58.96*** (6.584) 57.71*** (6.581)
t 9 age 25–29 56.33*** (6.454) 58.06*** (6.295) 56.65*** (6.292)
t 9 age 30–34 97.25*** (6.250) 101.9*** (6.096) 100.4*** (6.093)
t 9 age 35–39 130.4*** (6.152) 136.8*** (6.001) 135.0*** (5.999)
t 9 age 40–44 147.7*** (6.202) 155.7*** (6.049) 153.1*** (6.047)
t 9 age 45–49 164.5*** (6.401) 173.0*** (6.243) 168.9*** (6.242)
t 9 age 50–54 51.53*** (6.710) 183.3*** (6.454) 195.5*** (6.295) 188.6*** (6.296)
t 9 age 55–59 115.2*** (7.236) 243.0*** (7.008) 259.7*** (6.836) 249.3*** (6.842)
t 9 age 60–64 247.9*** (7.741) 371.8*** (7.537) 393.0*** (7.352) 375.7*** (7.372)
t 9 age 65–69 368.6*** (8.509) 476.6*** (8.336) 509.2*** (8.132) 481.4*** (8.182)
t 9 age 70–74 552.0*** (9.058) 625.7*** (8.901) 682.4*** (8.685) 636.8*** (8.816)
t 9 age 75–79 741.8*** (9.417) 790.2*** (9.268) 862.5*** (9.045) 783.7*** (9.421)
t 9 age 80–84 819.3*** (10.61) 867.9*** (10.49) 948.9*** (10.24) 811.9*** (11.23)
t 9 age 85–89 866.5*** (13.28) 939.4*** (13.22) 1,021.8*** (12.90) 787.4*** (15.12)
t 9 age 90? 778.4*** (18.61) 913.5*** (18.64) 976.4*** (18.19) 548.5*** (23.19)
Gender ðqÞ 197.4*** (11.55) -92.59*** (11.58) 222.7*** (11.38) 222.7*** (11.37)
Age ðcÞ
0 23,927.5*** (57.03) 9,705.0*** (107.8) 8,761.0*** (105.3) 8,783.9*** (105.3)
1–4 Reference Reference Reference Reference
5–9 -1,554.6*** (33.81) -1,368.4*** (63.77) -1,283.1*** (62.20) -1,285.0*** (62.18)
10–14 -1,847.8*** (33.81) -1,678.6*** (64.59) -1,592.9*** (63.00) -1,594.7*** (62.97)
15–19 -1,093.4*** (34.23) -962.8*** (65.62) -960.5*** (64.00) -959.7*** (63.97)
20–24 -80.42* (34.49) 96.26 (65.16) 35.33 (63.55) 38.47 (63.52)
25–29 956.1*** (33.83) 1,108.1*** (63.06) 1,063.5*** (61.51) 1,067.2*** (61.48)
30–34 1,368.6*** (33.09) 1,306.3*** (62.16) 1,252.2*** (60.63) 1,256.5*** (60.61)
35–39 1,011.4*** (32.89) 799.1*** (62.62) 706.4*** (61.08) 713.0*** (61.05)
40–44 985.8*** (33.17) 722.4*** (63.06) 569.6*** (61.51) 580.1*** (61.48)
45–49 1,760.5*** (33.55) 1,496.4*** (63.69) 1,240.6*** (62.13) 1,258.7*** (62.10)
50–54 2,807.8*** (50.25) 2,885.2*** (63.74) 2,453.2*** (62.20) 2,486.0*** (62.19)
55–59 4,405.1*** (54.24) 4,731.7*** (66.91) 4,076.6*** (65.34) 4,127.6*** (65.33)
60–64 6,089.4*** (59.61) 6,813.5*** (71.24) 5,831.2*** (69.64) 5,919.5*** (69.68)
65–69 8,264.0*** (62.92) 9,649.5*** (73.68) 8,200.5*** (72.18) 8,347.5*** (72.31)
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due to increased expenditures towards elderly in general
and increased expenditures for decedents [based on
Table 5, last regression]). However, the implication of the
results with regard to predictions of future health care
expenditures should be interpreted with care until to the
mechanisms that drive steepening are detected.
The only health care service included in this study is
inpatient in somatic hospitals; this is a limitation to this
study. If there is a substitution effect between different
health care services, excluding other services could
potentially lead to biased results. It may be plausible that
steepening is observed for inpatients, but the opposite
effect is observed in other health care services. Additional
research should therefore take place in other parts of the
health care sector in order to conﬁrm steepening outside
inpatient care.
The use of DRG-cost weights to measure expenditure
enables the study to investigate costs for different age and
gender groups over time. There are, however, some limi-
tations associated with using DRGs as a proxy for costs.
DRG-cost weights are the expected cost of a treatment for
the average patient and not the actual cost. As mentioned
by Melberg et al. [12], elderly individuals have poorer
health than the average patient, and the cost for this group
might therefore be underestimated. Conversely, for other
healthier groups, the use of DRG-weights may have over-
estimated actual costs.
In summary, our results clearly do not reject steepening in
per capita health care expenditures over time for the 50? age
group, with the exception of 0-year-olds. Mortality-related
expenditures also increase over time, and the effect of
steepening is reduced when this effect is taken into account.
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Table 5 continued
Dependent variable per capita expenditures ðYgÞ
Equation (14) (16) Excluding
mortalities
(16) Excluding the
interaction between time
and mortalities
(16) Including the
interaction between time
and mortalities
Independent variable Coefﬁcient Standard
er.
Coefﬁcient Standard
er.
Coefﬁcient Standard
er.
Coefﬁcient Standard
er.
70–74 10,326.0*** (64.89) 12,811.1*** (74.42) 10,679.8*** (73.21) 10,929.5*** (73.66)
75–79 11,538.5*** (68.44) 15,688.1*** (75.63) 12,646.0*** (74.99) 13,081.9*** (76.37)
80–84 10,803.2*** (79.57) 17,176.7*** (83.18) 13,006.6*** (83.41) 13,767.3*** (87.20)
85–89 8,676.3*** (101.8) 17,490.2*** (101.3) 12,186.2*** (103.3) 13,499.3*** (112.3)
90? 4,508.2*** (141.9) 14,703.5*** (136.1) 9,302.3*** (145.1) 11,712.1*** (166.1)
Mortality rate ðjÞ 131,415.8*** (871.7) 297,704.7*** (1,759.7) 289,556.8*** (1,780.1)
Mortality rate2 -446,127.2*** (7,069.6)
Mortality rate3 640,520.0*** (16,487.0)
Mortality rate4 -310,920.1*** (10,454.6)
Age 9 mortality rate ðgÞ -2,932.4*** (19.91) -2,966.2*** (19.93)
Mortality rate 9 t ðkÞ 2,045.9*** (68.79)
Constant ðaÞ 2,053.2*** (32.60) 2,881.3*** (50.74) 2,291.4*** (49.57) 2,294.2*** (49.55)
N 995,158 995,158 995,158 995,158
R2 0.605 0.598 0.618 0.618
Adjusted R2 0.605 0.598 0.618 0.618
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